Prenatal paternity testing using maternal blood, free floating fetal DNA and SNP genotyping
| Title: | Prenatal paternity testing using maternal blood, free floating fetal DNA and SNP genotyping |
|---|---|
| Patent Number: | 10113,196 |
| Publication Date: | October 30, 2018 |
| Appl. No: | 13/335043 |
| Application Filed: | December 22, 2011 |
| Abstract: | Methods for non-invasive prenatal paternity testing are disclosed herein. The method uses genetic measurements made on plasma taken from a pregnant mother, along with genetic measurements of the alleged father, and genetic measurements of the mother, to determine whether or not the alleged father is the biological father of the fetus. This is accomplished by way of an informatics based method that can compare the genetic fingerprint of the fetal DNA found in maternal plasma to the genetic fingerprint of the alleged father. |
| Inventors: | Ryan, Allison (Redwood City, CA, US); Sigurjonsson, Styrmir (San Jose, CA, US); Banjevic, Milena (Los Altos Hill, CA, US); Gemelos, George (San Jose, CA, US); Hill, Matthew (Menlo Park, CA, US); Baner, Johan (San Francisco, CA, US); Rabinowitz, Matthew (San Francisco, CA, US); Demko, Zachary (Los Altos Hills, CA, US) |
| Assignees: | Natera, Inc. (San Carlos, CA, US) |
| Claim: | 1. A method for establishing whether an alleged father is the biological father of a fetus that is gestating in a pregnant mother, the method comprising: obtaining genotypic measurements of single nucleotide polymorphism (SNP) alleles at a plurality of polymorphic loci on genetic material from the alleged father; obtaining fetal and maternal genotypic measurements of SNP alleles at the plurality of polymorphic loci from genetic material isolated from a blood sample from the pregnant mother, wherein the blood sample comprises a mixture of free floating DNA of fetal origin and free floating DNA of maternal origin, wherein the obtaining of fetal and maternal genotypic measurements comprises amplifying the plurality of polymorphic loci from the free floating DNA of fetal origin and the free floating DNA of maternal origin together in a single reaction and measuring the genotypes of the SNP alleles in the amplified DNA by a technique selected from the group consisting of quantitative PCR, digital PCR, SNP microarrays, DNA microarrays, and sequencing; determining a probability that the alleged father is the biological father of the fetus by calculating a test statistic for the alleged father and the fetus, wherein the test statistic for the alleged father and the fetus indicates a degree of genetic similarity between the alleged father and the fetus, and wherein the test statistic for the alleged father and the fetus is based on the genotypic measurements of SNP alleles made from genetic material from the alleged father and the genotypic measurements of SNP alleles made from genetic material isolated from the blood sample from the pregnant mother; determining a distribution of test statistics for a plurality of unrelated individuals and the fetus, where each of the test statistics for the plurality of unrelated individuals and the fetus indicates a degree of genetic similarity between an individual unrelated to the fetus and the fetus, wherein the test statistic is based on genotypic measurements of SNP alleles made from genetic material from the unrelated individual and the genotypic measurements of SNP alleles made from genetic material isolated from the blood sample from the pregnant mother; determining if the test statistic for the alleged father and the fetus belongs to the distribution of the test statistics for the plurality of unrelated individuals and the fetus; and outputting that the alleged father is the biological father of the fetus if the test statistic for the alleged father and the fetus does not belong to the distribution of the test statistics for the plurality of unrelated individuals and the fetus. |
| Claim: | 2. The method of claim 1 , wherein determining the probability that the alleged father is the biological father is performed using a maximum likelihood estimation, or a maximum a posteriori technique. |
| Claim: | 3. The method of claim 1 , wherein the polymorphic loci correspond to chromosomes that are disomic. |
| Claim: | 4. The method of claim 1 , wherein the method further comprises isolating the genetic material from the alleged father from a tissue selected from the group consisting of blood, somatic tissue, sperm, hair, buccal sample, skin, forensic samples, and combinations thereof. |
| Claim: | 5. The method of claim 1 , further comprising determining a confidence for the establishment of whether the alleged father is the biological father of the fetus. |
| Claim: | 6. The method of claim 1 , wherein the genotypes of the SNP alleles in the amplified DNA are measured using a technique or technology selected from the group consisting of Sanger DNA sequencing, pyrosequencing, high throughput sequencing, targeted sequencing using circularizing probes, targeted sequencing using capture by hybridization probes, reversible dye terminator sequencing, sequencing by ligation, and sequencing by hybridization. |
| Claim: | 7. The method of claim 1 , wherein the free floating DNA of fetal origin and the free floating DNA of maternal origin are amplified using a technique or technology that is selected from the group consisting of Polymerase Chain Reaction (PCR), ligation mediated PCR, degenerative oligonucleotide primer PCR, targeted amplification, PCR, mini-PCR, universal PCR amplification, Multiple Displacement Amplification (MDA), linear amplification methods, ligation of substrate DNA followed by another method of amplification, bridge amplification, padlock probes, circularizing probes, and capture by hybridization probes. |
| Claim: | 8. The method of claim 1 , further comprising generating a report comprising the probability of paternity of the fetus. |
| Claim: | 9. The method of claim 1 , wherein the polymorphic loci comprise short tandem repeats (STRs). |
| Claim: | 10. The method of claim 1 , further comprising outputting the determined probability that the alleged father is the biological father of the fetus. |
| Claim: | 11. The method of claim 1 , wherein the test statistic calculated for the alleged father and the fetus does not belong to the distribution of the test statistics calculated for the plurality of unrelated individuals and the fetus if the P value of the alleged father's test statistic according to the distribution of unrelated individuals is less than 10 −4 . |
| Claim: | 12. The method of claim 1 , wherein the test statistic calculated for the alleged father and the fetus does belong to the distribution of the test statistics calculated for the plurality of unrelated individuals and the fetus if the P value of the alleged father's test statistic according to the distribution of unrelated individuals is greater than 0.02. |
| Claim: | 13. A method for establishing whether an alleged father is the biological father of a fetus that is gestating in a pregnant mother, the method comprising: obtaining genotypic measurements of SNP alleles at a plurality of polymorphic loci on genetic material from the alleged father; obtaining genotypic measurements of SNP alleles at the plurality of polymorphic loci on genetic material from a plurality of individuals who are genetically unrelated to the fetus; obtaining fetal and maternal genotypic measurements of SNP alleles at the plurality of polymorphic loci from genetic material isolated from a blood sample from the pregnant mother, wherein the blood sample comprises a mixture of free floating DNA of fetal origin and free floating DNA of maternal origin, wherein the obtaining of fetal and maternal genotypic measurements comprises amplifying the plurality of polymorphic loci from the free floating DNA of fetal origin and the free floating DNA of maternal origin together in a single reaction and measuring the genotypes of the SNP alleles in the amplified DNA by a technique selected from the group consisting of quantitative PCR, digital PCR, SNP microarrays, DNA microarrays, and sequencing; calculating a test statistic for the alleged father, wherein the test statistic for the alleged father indicates a degree of genetic similarity between the alleged father and the fetus, and wherein the test statistic for the alleged father is a function of the genotypic measurements of SNP alleles made on the genetic material from the alleged father and the genetic material isolated from the blood sample from the pregnant mother; calculating a test statistic for each individual in the plurality of unrelated individuals, wherein the test statistic for each unrelated individual indicates a degree of genetic similarity between the unrelated individual and the fetus, and wherein the test statistic for each unrelated individual is a function of genotypic measurements of SNP alleles made on the genetic material from the unrelated individual and the genetic material isolated from the blood sample from the pregnant mother; determining whether the test statistic for the alleged father belongs to a distribution of the test statistic for the plurality of unrelated individuals; and outputting that the alleged father is the biological father if the test statistic for the alleged father does not belong to the distribution of the test statistic for the plurality of unrelated individuals. |
| Claim: | 14. The method of claim 13 , wherein establishing whether the alleged father is the biological father of the fetus further comprises: establishing that the alleged father is the biological father of the fetus by rejecting a hypothesis that the alleged father is unrelated to the fetus if the probability that the test statistic for the alleged father belongs to the distribution of the test statistic for the plurality of unrelated individuals is below a lower threshold; or establishing that the alleged father is not the biological father of the fetus by not rejecting a hypothesis that the alleged father is unrelated to the fetus if the probability is above an upper threshold; or not establishing whether an alleged father is the biological father of the fetus if the probability is between the lower threshold and the upper threshold, or if the probability is not determined with sufficiently high confidence. |
| Claim: | 15. The method of claim 13 , further comprising obtaining genotypic measurements at the plurality of polymorphic loci from a sample that consists essentially of genetic material from the mother; wherein the test statistic for the alleged father is a function of the genotypic measurements made on the genetic material from the alleged father, the sample that consists essentially of genetic material from the mother, and the genetic material isolated from the blood sample from the pregnant mother and wherein the test statistic for the unrelated individual is a function of genotypic measurements made on the genetic material from the unrelated individual, the sample that consists essentially of genetic material from the mother, and the genetic material isolated from the blood sample from the pregnant mother; calculating a probability that the test statistic for the alleged father is part of the distribution of the test statistic for the plurality of unrelated individuals; and determining a probability that the alleged father is the biological father of the fetus using the probability that the test statistic for the alleged father is part of the distribution of the test statistic for the plurality of unrelated individuals. |
| Claim: | 16. The method of claim 13 , wherein the test statistic calculated for the alleged father and the fetus does not belong to the distribution of the test statistics calculated for the plurality of unrelated individuals and the fetus if the P value of the alleged father's test statistic according to the distribution of unrelated individuals is less than 10 −4 . |
| Claim: | 17. The method of claim 13 , wherein the test statistic calculated for the alleged father and the fetus does belong to the distribution of the test statistics calculated for the plurality of unrelated individuals and the fetus if the P value of the alleged father's test statistic according to the distribution of unrelated individuals is greater than 0.02. |
| Patent References Cited: | 5635366 June 1997 Cook 5716776 February 1998 Bogart 5753467 May 1998 Jensen et al. 5824467 October 1998 Mascarenhas 5860917 January 1999 Comanor 5972602 October 1999 Hyland et al. 5994148 November 1999 Stewart 6001611 December 1999 Will 6025128 February 2000 Veltri 6108635 August 2000 Herren 6143496 November 2000 Brown et al. 6180349 January 2001 Ginzinger et al. 6214558 April 2001 Shuber et al. 6258540 July 2001 Lo et al. 6300077 October 2001 Shuber et al. 6440706 August 2002 Vogelstein et al. 6479235 November 2002 Schumm et al. 6489135 December 2002 Parrott 6720140 April 2004 Hartley 6807491 October 2004 Pavlovic et al. 6852487 February 2005 Barany et al. 6958211 October 2005 Vingerhoets 6964847 November 2005 Englert 7035739 April 2006 Schadt 7058517 June 2006 Denton 7058616 June 2006 Larder 7218764 May 2007 Vaisberg 7297485 November 2007 Bornarth 7332277 February 2008 Dhallan 7414118 August 2008 Mullah et al. 7442506 October 2008 Dhallan 7459273 December 2008 Jones et al. 7645576 January 2010 Lo et al. 7700325 April 2010 Cantor et al. 7718367 May 2010 Lo et al. 7718370 May 2010 Dhallan 7727720 June 2010 Dhallan 7805282 September 2010 Casey et al. 7838647 November 2010 Hahn et al. 7888017 February 2011 Quake et al. 8008018 August 2011 Quake et al. 8024128 September 2011 Rabinowitz et al. 8137912 March 2012 Kapur et al. 8168389 May 2012 Shoemaker et al. 8195415 June 2012 Fan et al. 8296076 October 2012 Fan et al. 8304187 November 2012 Fernando 8318430 November 2012 Chuu et al. 8467976 June 2013 Lo et al. 8515679 August 2013 Rabinowitz et al. 8532930 September 2013 Rabinowitz et al. 8682592 March 2014 Rabinowitz et al. 8825412 September 2014 Rabinowitz et al. 9085798 July 2015 Chee 9476095 October 2016 Vogelstein et al. 9487829 November 2016 Vogelstein et al. 9598731 March 2017 Talasaz 9677118 June 2017 Zimmermann et al. 2001/0053519 December 2001 Fodor et al. 2002/0006622 January 2002 Bradley et al. 2002/0107640 August 2002 Ideker et al. 2003/0009295 January 2003 Markowitz 2003/0065535 April 2003 Karlov 2003/0077586 April 2003 Pavlovic et al. 2003/0101000 May 2003 Bader 2003/0119004 June 2003 Wenz et al. 2003/0228613 December 2003 Bornarth 2004/0033596 February 2004 Threadgill 2004/0137470 July 2004 Dhallan 2004/0146866 July 2004 Fu 2004/0157243 August 2004 Huang et al. 2004/0197797 October 2004 Inoko et al. 2004/0209299 October 2004 Pinter et al. 2004/0229231 November 2004 Frudakis et al. 2004/0236518 November 2004 Pavlovic 2004/0259100 December 2004 Gunderson et al. 2005/0007953 January 2005 Hirose et al. 2005/0009069 January 2005 Liu 2005/0049793 March 2005 Paterlini-Brechot 2005/0123914 June 2005 Katz et al. 2005/0130173 June 2005 Leamon et al. 2005/0142577 June 2005 Jones et al. 2005/0144664 June 2005 Smith 2005/0164241 July 2005 Hahn et al. 2005/0221341 October 2005 Shimkets et al. 2005/0227263 October 2005 Green et al. 2005/0250111 November 2005 Xie 2005/0255508 November 2005 Casey et al. 2005/0272073 December 2005 Vaisberg 2006/0019278 January 2006 Lo et al. 2006/0040300 February 2006 Dapprich 2006/0052945 March 2006 Rabinowtiz 2006/0057618 March 2006 Piper 2006/0068394 March 2006 Langmore et al. 2006/0088574 April 2006 Manning et al. 2006/0099614 May 2006 Gill et al. 2006/0121452 June 2006 Dhallan 2006/0134662 June 2006 Pratt 2006/0141499 June 2006 Sher 2006/0210997 September 2006 Myerson et al. 2006/0216738 September 2006 Wada et al. 2006/0229823 October 2006 Liu 2006/0281105 December 2006 Li et al. 2007/0027636 February 2007 Rabinowitz 2007/0042384 February 2007 Li et al. 2007/0059707 March 2007 Cantor 2007/0122805 May 2007 Cantor et al. 2007/0128624 June 2007 Gormley et al. 2007/0178478 August 2007 Dhallan 2007/0178501 August 2007 Rabinowitz 2007/0184467 August 2007 Rabinowitz 2007/0202525 August 2007 Quake et al. 2007/0202536 August 2007 Yamanishi et al. 2007/0207466 September 2007 Cantor 2007/0212689 September 2007 Bianchi 2007/0243549 October 2007 Bischoff 2007/0259351 November 2007 Chinitz 2008/0020390 January 2008 Mitchell 2008/0026390 January 2008 Stoughton et al. 2008/0038733 February 2008 Bischoff et al. 2008/0070792 March 2008 Stoughton 2008/0071076 March 2008 Hahn et al. 2008/0085836 April 2008 Kearns et al. 2008/0102455 May 2008 Poetter 2008/0138809 June 2008 Kapur et al. 2008/0182244 July 2008 Tafas 2008/0193927 August 2008 Mann et al. 2008/0220422 September 2008 Shoemaker et al. 2008/0234142 September 2008 Lietz 2008/0243398 October 2008 Rabinowitz 2009/0023190 January 2009 Lao et al. 2009/0029377 January 2009 Lo et al. 2009/0087847 April 2009 Lo et al. 2009/0098534 April 2009 Weier et al. 2009/0099041 April 2009 Church et al. 2009/0143570 June 2009 Jiang et al. 2009/0176662 July 2009 Rigatti et al. 2009/0221620 September 2009 Luke et al. 2010/0035232 February 2010 Ecker et al. 2010/0112575 May 2010 Fan et al. 2010/0112590 May 2010 Lo et al. 2010/0120038 May 2010 Mir et al. 2010/0124751 May 2010 Quake et al. 2010/0138165 June 2010 Fan et al. 2010/0171954 July 2010 Quake et al. 2010/0184069 July 2010 Fernando et al. 2010/0184152 July 2010 Sandler et al. 2010/0196892 August 2010 Quake et al. 2010/0203538 August 2010 Dube et al. 2010/0216153 August 2010 Lapidus et al. 2010/0248231 September 2010 Wei et al. 2010/0255492 October 2010 Quake et al. 2010/0256013 October 2010 Quake et al. 2010/0273678 October 2010 Alexandre et al. 2010/0285537 November 2010 Zimmermann 2010/0291572 November 2010 Stoughton et al. 2010/0323352 December 2010 Lo et al. 2011/0007103 January 2011 Han et al. 2011/0033862 February 2011 Rabinowitz 2011/0039724 February 2011 Lo et al. 2011/0086769 April 2011 Oliphant et al. 2011/0092763 April 2011 Rabinowitz et al. 2011/0105353 May 2011 Lo et al. 2011/0151442 June 2011 Fan et al. 2011/0160078 June 2011 Fodor et al. 2011/0178719 July 2011 Rabinowitz et al. 2011/0201507 August 2011 Rava et al. 2011/0224087 September 2011 Quake et al. 2011/0246083 October 2011 Fan et al. 2011/0251149 October 2011 Perrine et al. 2011/0288780 November 2011 Rabinowitz et al. 2011/0300608 December 2011 Ryan et al. 2011/0301854 December 2011 Curry et al. 2011/0318734 December 2011 Lo et al. 2012/0003635 January 2012 Lo et al. 2012/0010085 January 2012 Rava et al. 2012/0034603 February 2012 Oliphant et al. 2012/0122701 May 2012 Ryan et al. 2012/0165203 June 2012 Quake et al. 2012/0185176 July 2012 Rabinowitz et al. 2012/0190020 July 2012 Oliphant et al. 2012/0190021 July 2012 Oliphant et al. 2012/0191358 July 2012 Oliphant 2012/0196754 August 2012 Quake et al. 2012/0214678 August 2012 Rava et al. 2012/0264121 October 2012 Rava et al. 2012/0270212 October 2012 Rabinowitz et al. 2012/0295819 November 2012 Leamon et al. 2013/0017549 January 2013 Hong 2013/0024127 January 2013 Stuelpnagel et al. 2013/0034546 February 2013 Rava et al. 2013/0060483 March 2013 Struble et al. 2013/0069869 March 2013 Akao et al. 2013/0090250 April 2013 Sparks et al. 2013/0116130 May 2013 Fu et al. 2013/0123120 May 2013 Zimmermann et al. 2013/0178373 July 2013 Rabinowitz et al. 2013/0190653 July 2013 Alvarez Ramos 2013/0196862 August 2013 Rabinowitz et al. 2013/0210644 August 2013 Stoughton et al. 2013/0225422 August 2013 Rabinowitz et al. 2013/0252824 September 2013 Rabinowitz et al. 2013/0253369 September 2013 Rabinowitz et al. 2013/0261004 October 2013 Ryan et al. 2013/0274116 October 2013 Rabinowitz et al. 2013/0303461 November 2013 Iafrate et al. 2013/0323731 December 2013 Lo et al. 2014/0032128 January 2014 Rabinowitz et al. 2014/0051585 February 2014 Prosen et al. 2014/0065621 March 2014 Mhatre et al. 2014/0087385 March 2014 Rabinowitz et al. 2014/0094373 April 2014 Zimmermann et al. 2014/0100126 April 2014 Rabinowitz 2014/0100134 April 2014 Rabinowitz et al. 2014/0141981 May 2014 Zimmermann et al. 2014/0154682 June 2014 Rabinowitz et al. 2014/0162269 June 2014 Rabinowitz et al. 2014/0193816 July 2014 Rabinowitz et al. 2014/0206552 July 2014 Rabinowitz et al. 2014/0227705 August 2014 Vogelstein et al. 2014/0256569 September 2014 Rabinowitz et al. 2014/0272956 September 2014 Huang et al. 2014/0287934 September 2014 Szelinger et al. 2014/0329245 November 2014 Spier et al. 2014/0336060 November 2014 Rabinowitz 2015/0051087 February 2015 Rabinowitz et al. 2015/0064695 March 2015 Katz et al. 2015/0147815 May 2015 Babiarz et al. 2015/0197786 July 2015 Osborne et al. 2015/0232938 August 2015 Mhatre 2015/0265995 September 2015 Head et al. 2016/0201124 July 2016 Donahue et al. 2016/0257993 September 2016 Fu et al. 2016/0289740 October 2016 Fu et al. 2016/0289753 October 2016 Osborne et al. 2016/0312276 October 2016 Fu et al. 2016/0319345 November 2016 Gnerre et al. 2017/0121716 May 2017 Rodi et al. 1674028 September 2005 1 524 321 April 2005 1524321 April 2005 1524321 July 2009 2163622 March 2010 2902500 Al August 2015 2488358 August 2012 2965699 August 1999 2002-530121 September 2002 2004502466 January 2004 2004533243 November 2004 2005514956 May 2005 2005160470 June 2005 2005160470 June 2005 2006-254912 September 2006 2011/516069 May 2011 WO-0179851 October 2001 200190419 November 2001 WO 2001/090419 November 2001 WO-0204672 January 2002 WO-02055985 July 2002 WO2002076377 October 2002 WO 2003/031646 April 2003 WO-03050532 June 2003 WO-03062441 July 2003 0190419 November 2003 WO-03102595 December 2003 WO-03106623 December 2003 WO-2004087863 October 2004 WO-2005021793 March 2005 WO-2005035725 April 2005 WO-2005100401 October 2005 WO-2005123779 December 2005 WO 2007/057647 May 2007 WO 2007/062164 May 2007 WO-2007057647 May 2007 2007070482 June 2007 WO 2007/070482 June 2007 WO 2007/132167 November 2007 WO2007147074 December 2007 WO-2008024473 February 2008 WO-2008024473 February 2008 WO-2008048931 April 2008 2008059578 May 2008 WO-2008051928 May 2008 WO-2008051928 May 2008 WO-2008081451 July 2008 WO 2008/115497 September 2008 WO-2008135837 November 2008 WO-2008157264 December 2008 WO 2009/013492 January 2009 WO 2009/013496 January 2009 WO-2009009769 January 2009 WO 2009/019455 February 2009 WO-2009019215 February 2009 2009/036525 March 2009 WO-2009030100 March 2009 WO-2009032779 March 2009 WO-2009032781 March 2009 WO-2009033178 March 2009 WO-2009091934 July 2009 WO-2009092035 July 2009 WO 2009/105531 August 2009 WO 2009/146335 December 2009 WO 2010/017214 February 2010 2010/033652 March 2010 WO2010075459 July 2010 WO 2011/041485 April 2011 WO2011057094 May 2011 WO2011087760 July 2011 WO 2011/146632 November 2011 20120071621 June 2012 WO 2012/088456 June 2012 WO201283250 June 2012 WO 2012/108920 August 2012 2012/142531 October 2012 2007/149791 December 2012 WO2013030577 March 2013 2013/045432 April 2013 WO-2013052557 April 2013 2013/078470 May 2013 2013/086464 June 2013 20130130848 September 2013 2014/004726 January 2014 2014/014497 January 2014 20140018080 January 2014 2014/149134 September 2014 2014/151117 September 2014 2015/100427 July 2015 2015/164432 October 2015 2016/009059 January 2016 2016/065295 April 2016 2018/083467 May 2018 |
| Other References: | Gjertson, “Assessing probability of paternity and the product rule in DNA systems,” Genetica, vol. 96, pp. 89-98, 1995. cited by examiner Guetta, “Analysis of Fetal Blood Cells in the Maternal Circulation: Challenges, Ongoing Efforts, and Potential Solutions,” Stem Cells and Development, vol. 13, pp. 93-99, 2004. cited by examiner Ellonen, “Development of SNP microarray for supplementary paternity testing,” Int'l Congress Series, vol. 1261, pp. 12-14, 2004. cited by examiner Carnevale, “Attitudes of Mexican Geneticists Towards Prenatal Diagnosis and Selective Abortion,” Am. J. Med. Genetics, vol. 75, pp. 426-431, 1998. cited by examiner Chakraborty, “Paternity exclusion by DNA markers: effects of paternal mutations,” vol. 41(4), p. 671-677, 1996. cited by examiner Pearson, “On the criterion that a given system of deviations from the probable in the case of a correlated system of variables is such that it can be reasonably supposed to have arisen from random sampling,” Philosophical Magazine Series 5, vol. 50(302), p. 157-175, 1900. cited by examiner Wu, “Rapid and/or high-throughput genotyping for human red blood cell, platelet and leukocyte antigens, and forensic applications,” Clinical Chimica Acta, vol. 363, p. 165-176, 2006. cited by examiner Wright, “Cell-free fetal DNA and RNA in maternal blood: implications for safer antenatal testing,” BMJ, vol. 339:b2451, p. 161-165, Jul. 18, 2009. cited by examiner Ashoor et al., Chromosome-Selective Sequencing of Maternal Plasma Cell-Free DNA for First-Trimester Detection of Trisomy 21 and Trisomy 18, American Journal of Obstetrics & Gynecology, 206(4), pp. 322.e1-322.e5 (Apr. 2012). cited by applicant Beer et al., The Biological Basis of Passage of Fetal Cellular Material into the Maternal Circulation, Annals New York Academy of Sciences, 731, pp. 21-35 (Sep. 7, 1994). cited by applicant Bisignano et al., PGD and Aneuploidy Screening for 24 Chromosomes: Advantages and Disadvantages of Competing Platforms, Reproductive BioMedicine Online, 23(6), pp. 677-685 (Dec. 2011). cited by applicant Chen et al., Noninvasive Prenatal Diagnosis of Fetal Trisomy 18 and Trisomy 13 by Maternal Plasma DNA Sequencing, PLoS ONE, 6(7), pp. 1-7 (Jul. 2011). cited by applicant Chiu et al., Noninvasive Prenatal Diagnosis of Fetal Chromosomal Aneuploidy by Massively Parallel Genomic Sequencing of DNA in Maternal Plasma, PNAS, 105(51), pp. 20458-20463 (Dec. 23, 2008). cited by applicant Chiu et al., Supporting Information, PNAS, 105(51), pp. 1-17 (Dec. 23, 2008). cited by applicant Chiu et al., Maternal Plasma DMA Analysis with Massively Parallel Sequencing by Litigation for Noninvasive Prenatal Diagnosis of Trisomy 21, Clinical Chemistry, 56(3), pp. 459-463 (Mar. 2010). cited by applicant Chu et al., Statistical Considerations for Digital Approaches to Non-Invasive Fetal Genotyping, Bioinformatics, 26(22), pp. 2863-2866 (Sep. 23, 2010). cited by applicant Chu et al., A Novel Approach Toward the Challenge of Accurately Quantifying Fetal DNA in Maternal Plasma, Prenatal diagnosis, 30, pp. 1226-1229 (Nov. 11, 2010). cited by applicant Cossu et al., Rh D/d Genotyping by Quantitative Polymerase Chain Reaction and Capillary Zone Electrophoresis, Electrophoresis, 17(12), pp. 1911-1915 (Dec. 1996). cited by applicant DeAngelis et al., Solid-phase Reversible Immobilization for the Isolation of PCR Products, Nucleic Acids Research, 23(22), pp. 4742-4743 (Nov. 25, 1995). cited by applicant Devaney et al., Noninvasive Fetal Sex Determination Using Cell-Free Fetal DNA: A Systematic Review and Meta-analysis, JAMA, 306(6), pp. 627-636 (Aug. 10, 2011). cited by applicant Dhallan et al., Methods to Increase the Percentage of Free Fetal DNA Recovered from the Maternal Circulation, JAMA, 291(9), pp. 1114-1119 (Mar. 3, 2004). cited by applicant Eichler et al., Mild Course of Fetal RhD Haemolytic Disease due to Maternal Alloimmunisation to Paternal HLA Class I and II Antigens, Vox Sang, 68(4), pp. 243-247 (1995). cited by applicant Gänshirt-Ahlert et al., Three Cases of 45,X/46,XYnf Mosaicism, Hum Genet, 76(2), pp. 153-156 (Jun. 1987). cited by applicant Gänshirt-Ahlert et al., Ratio of Fetal to Maternal DNA is Less Than 1 in 5000 at different Gestational Ages in Maternal Blood, Clinical Genetics, 38(1), pp. 38-43 (Jul. 1990). cited by applicant Gänshirt-Ahlert et al., Fetal DNA in Uterine Vein Blood, Obstetrics & Gynecology, 80(4), pp. 601-603 (Oct. 1992). cited by applicant Ghanta et al., Non-Invasive Prenatal Detection of Trisomy 21 Using Tandem Single Nucleotide Polymorphisms, PLoS ONE, 5(10), pp. 1-10 (Oct. 2010). cited by applicant Greenwalt et al., The Quantification of Fetomaternal Hemorrhage by an Enzyme-Linked Antibody Test with Glutaraldehyde Fixation, Vox Sang, 63(4), pp. 238-271 (1992). cited by applicant Homer et al., Resolving Individuals Contributing Trace Amounts of DNA to Highly Complex Mixtures Using High-Density SNP Genotyping Microarrays, PLOS Genetics, 4(8), pp. 1-9 (Aug. 2008). cited by applicant Kazakov et al., Extracellular DNA in the Blood of Pregnant Women, Tsitologia, 37(3), pp. 1-8 (1995). cited by applicant Lambert-Messerlian et al., Adjustment of Serum Markers in First Trimester Screening, Journal of Medical Screening 16(2), pp. 102-103 (2009). cited by applicant Li et al., Non-Invasive Prenatal Diagnosis Using Cell-Free Fetal DNA in Maternal Plasma from PGD Pregnancies, Reproductive BioMedicine Online, 19(5), pp. 714-720 (Nov. 2009). cited by applicant Lo et al., Prenatal Sex Determination by DNA Amplification from Maternal Peripheral Blood, The Lancet, 2(8676), pp. 1363-1365 (Dec. 9, 1989). cited by applicant Lo et al., Detection of Single-Copy Fetal DNA Sequence from Maternal Blood, The Lancet, 335, pp. 1463-1464 (Jun. 16, 1990). cited by applicant Lo et al., Letters to the Editor: Prenatal Determination of Fetal RhD Status by Analysis of Peripheral Blood of Rhesus Negative Mothers, The Lancet, 341, pp. 1147-1148 (May 1, 1993). cited by applicant Lo et al., Detection of Fetal RhD Sequence from Peripheral Blood of Sensitized RhD-Negative Pregnant Women, British Journal of Haematology, 87, pp. 658-660 (Apr. 22, 1994). cited by applicant Lo et al., Prenatal Determination of Fetal Rhesus D Status by DNA Amplification of Peripheral Blood of Rhesus-Negative Mothers, Annals New York Academy of Sciences, 731, pp. 229-236 (Sep. 7, 1994). cited by applicant Lo et al., Strategies for the Detection of Autosomal Fetal DNA Sequence from Maternal Peripheral Blood, Annals New York Academy of Sciences, 731, pp. 204-213 (Sep. 7, 1994). cited by applicant Lo et al., Rapid Clearance of Fetal DNA from Maternal Plasma, Am. J. Hum. Genet., 64(1), pp. 218-224 (Jan. 1999). cited by applicant Lo et al., Letter to the Editor: Free Fetal DNA in Maternal Circulation, JAMA, 292(23), pp. 2835-2836 (Dec. 15, 2004). cited by applicant Lo et al., Digital PCR for the Molecular Detection of Fetal Chromosomal Aneuploidy, PNAS, 104(32), pp. 13116-13121 (Aug. 7, 2007). cited by applicant Lo, Fetal Nucleic Acids in Maternal Plasma: Toward the Development of Noninvasive Prenatal Diagnosis of Chromosomal Aneuploidies, Ann. N.Y. Acad. Sci., 1137, pp. 140-143 (Aug. 2008). cited by applicant Maniatis et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, pp. 458-459 (Jul. 1982). cited by applicant Mansfield, Diagnosis of Down Syndrome and Other Aneuploidies Using Quantitative Polymerase Chain Reaction and Small Tandem Repeat Polymorphisms, Human Molecular Genetics, 2(1), pp. 43-50 (Jan. 1993). cited by applicant Orozco et al., Placental Release of Distinct DNA-Associated Micro-Particles into Maternal Circulation: Reflective of Gestation Time and Preeclampsia, Placenta, 30(10), pp. 891-897 (Oct. 2009). cited by applicant Ozawa et al., Two Families with Fukuyama Congenital Muscular Dystrophy that Underwent In Utero Diagnosis Based on Polymorphism Analysis, Clinical Muscular Dystrophy: Research in Immunology and Genetic Counseling—FY 1994/1995, pp. 13-15 (Mar. 28, 1996). cited by applicant Palomaki et al., DNA Sequencing of Maternal Plasma to Detect Down Syndrome: An International Clinical Validation Study, Genetics in Medicine, 13(11), pp. 913-920 (Nov. 2011). cited by applicant Papageorgiou et al., Fetal-Specific DNA Methylation Ratio Permits Noninvasive Prenatal Diagnosis of Trisomy 21, Nature Medicine, 17, pp. 510-513 (Mar. 6, 2011). cited by applicant Pena et al., Reviews: Paternity Testing in the DNA Era, TIG, 10(6), pp. 204-209 (Jun. 1994). cited by applicant Peters et al., Noninvasive Prenatal Diagnosis of a Fetal Microdeletion Syndrome, The New England Journal of Medicine, 365(19), pp. 1847-1848 (Nov. 10, 2011). cited by applicant Phillips et al., Resolving Relationship Tests that Show Ambiguous STR Results Using Autosomal SNPs as Supplementary Markers, Forensic Science International: Genetics 2, 2(3), pp. 198-204 (Jun. 2008). cited by applicant Roper et al., Forensic Aspects of DNA-Based Human Identity Testing, Journal of Forensic Nursing 4(4), pp. 150-156 (2008). cited by applicant Sehnert et al., Optimal Detection of Fetal Chromosomal Abnormalities by Massively Parallel DNA Sequencing of Cell-Free Fetal DNA from Maternal Blood, Clinical Chemistry, 57(7), pp. 1-8 (Apr. 25, 2011). cited by applicant Simpson et al., Fetal Cells in Maternal Blood: Overview and Historical Perspective, Annals New York Academy of Sciences, 731, pp. 1-8 (Sep. 1994). cited by applicant Sparks et al., Selective Analysis of Cell-Free DNA in Maternal Blood for Evaluation of Fetal Trisomy, Prenatal Diagnosis, 32, pp. 1-7 (Jan. 6, 2012). cited by applicant Sparks et al., Non-Invasive Prenatal Detection and Selective Analysis of Cell-Free DNA Obtained from Maternal Blood: Evaluation for Trisomy 21 and Trisomy 18, American Journal of Obstetrics & Gynecology, 206(4), pp. 319.e1-319.e9 (Apr. 2012). cited by applicant Stroun et al., Prehistory of the Notion of Circulating Nucleic Acids in Plasma/Serum (CNAPS): Birth of a Hypothesis, Ann. N.Y. Acad. Sci., 1075, pp. 10-20 (Sep. 2006). cited by applicant Thomas et al., The Time of Appearance and Disappearance of Fetal DNA from the Maternal Circulation, Prenatal Diagnosis, 15(7), pp. 641-646 (Jul. 1995). cited by applicant Tong et al., Noninvasive Prenatal Detection of Trisomy 21 by an Epigenetic-Genetic Chromosome-Dosage Approach, Clinical Chemistry, 56(1), pp. 90-98 (Jan. 2010). cited by applicant PCT International Search Report based on PCT/US2011/061506 dated Mar. 16, 2012. cited by applicant Abidi et al., Leveraging XML-based Electronic Medical Records to Extract Experimental Clinical Knowledge, International Journal of Medical Informatics, 68, p. 187-203 (Dec. 18, 2002). cited by applicant Allaire, Mate Selection by Selection Index Theory, Theor. Appl. Genet., 57, p. 267-272 (Nov. 1980). cited by applicant Bada et al., Computational Modeling of Structural Experimental Data, Methods in Enzymology, 317, p. 470-491 (May 2000). cited by applicant Beaumont et al., The Bayesian Revolution in Genetics, Nature Reviews Genetics, 5 (4), p. 251-261 (Apr. 2004). cited by applicant Beerenwinkel et al., Geno2pheno: Estimating Phenotypic Drug Resistance from HIV-1 Genotypes, Nucleic Acids Research, 31 (13), p. 3850-3855 (Jul. 2003). cited by applicant Beerenwinkel et al., Methods for Optimizing Antiviral Combination Therapies, Bioinformatics, 19 (3), p. i16-i25 (Jul. 2003). cited by applicant Bodenreider, The Unified Medical Language System (UMLS): Integrating Biomedical Terminology, Nucleic Acids Research, 32, p. D267-D270 (Jan. 2004). cited by applicant Breithaupt, The Future of Medicine, European Molecular Biology Organization, 2 (6), p. 465-467 (Jun. 2001). cited by applicant Chiu et al., Non-Invasive Prenatal Assessment of Trisomy 21 by Multiplexed Maternal Plasma DNA Sequencing: Large Scale Validity Study, BMJ, 342(7790), p. 1-9 (Jan. 2011). cited by applicant Chiu et al., Non-Invasive Prenatal Diagnosis by Single Molecule Counting Technologies, Trends in Genetics, 25(7), p. 324-331 (Jul. 2009). cited by applicant Chu et al., Statistical Model for Whole Genome Sequencing and its Application to Minimally Invasive Diagnosis of Fetal Genetic Disease, Bioinformatics, 25(10), p. 1244-1250 (May 15, 2009). cited by applicant Colella et al., QuantiSNP: an Objectives Bayes Hidden-Markov Model to Detect and Accurately Map Copy Number Variation Using SNP Genotyping Data, Nucleic Acids Research, 35 (6), p. 2013-2025 (Mar. 2007). cited by applicant Coyle et al., Standards for Detailed Clinical Models as the Basis for Medical Data Exchange and Decision Support, International Journal of Medical Informatics, 69 (2), p. 157-174 (Mar. 2003). cited by applicant Daruwala et al., A Versatile Statistical Analysis Algorithm to Detect Genome Copy Number Variation, PNAS, 101(46), p. 16292-16297(Nov. 16, 2004). cited by applicant Dhallan et al., A Non-Invasive Test for Prenatal Diagnosis Based on Fetal DNA Present in Maternal Blood: A Preliminary Study, Lancet, 369(9560), p. 474-481 (Feb. 2007). cited by applicant Donoso et al., Current Value of Preimplantation Genetic Aneuploidy Screening in IVF, Hum. Reprod. Update, 13 (1), p. 15-25 (Jan./Feb. 2007). cited by applicant Ehrich et al., Noninvasive Detection of Fetal Trisomy 21 by Sequencing of DNA in Maternal Blood: A Study in a Clinical Setting, AJOG, 204(3), p. 205.e1-205.e11 (Mar. 2011). cited by applicant Fan et al., Noninvasive Diagnosis of Fetal Aneuploidy by Shotgun Sequencing DNA from Maternal Blood, PNAS, 105(42), p. 16266-16271 (Oct. 2008). cited by applicant Fiorentino et al., Development and Clinical Application of a Strategy for Preimplantation Genetic Diagnosis of Single Gene Disorders Combined with HLA Matching, Molecular Human Reproduction, 10 (6), p. 445-460 (Jun. 2004). cited by applicant Fiorentino et al., Short Tandem Repeats Haplotyping of the HLA Region in Preimplantation HLA Matching, European J. Human Genetics, 13 (8), p. 953-958 (Aug. 2005). cited by applicant Fiorentino et al., Strategies and Clinical Outcome of 250 Cycles of Preimplantation Genetic Diagnosis for Single Gene Disorders, Human Reproduction, 21 (3), p. 670-684 (Mar. 2006). cited by applicant Fixed Medium, Academic Press Dictionary of Science and Technology, Retrieved from www.credoreference.com/entry/apdst/fixed_medium (Sep. 1992, Accessed on Nov. 18, 2009). cited by applicant Freeman et al., Copy Number Variation: New Insights in Genome Diversity, Genome Research, 16 (8), p. 949-961 (Aug. 2006). cited by applicant Gardina et al., Ploidy Status and Copy Number Aberrations in Primary Glioblastomas Defined by Integrated Analysis of Allelic Ratios, Signal Ratios and Loss of Heterozygosity Using 500K SNP Mapping Arrays, BMC Genomics, 9(489), pp. 1-16 (Oct. 2008). cited by applicant Harper et al., Recent Advances and Future Developments in PGD, Prenatal Diagnosis, 19, p. 1193-1199 (Dec. 1999). cited by applicant Hellani et al., Clinical Application of Multiple Displacement Amplification in Preimplantation Genetic Diagnosis, Reproductive BioMedicine Online, 10 (3), p. 376-380 (Jan. 13, 2005). cited by applicant Hojsgaard et al., BIFROST—Block Recursive Models Induced from Relevant Knowledge, Observations, and Statistical Techniques, Computational Statistics & Data Analysis, 19(2), p. 155-175 (Feb. 1995). cited by applicant Hollox et al., Extensive Normal Copy Number Variation of a β-Defensin Antimicrobial-Gene Cluster, Am. J. Hum. Genet., 73 (3), p. 591-600 (Sep. 2003). cited by applicant Hu et al., Aneuploidy Detection in Single Cells Using DNA Array-Based Comparative Genomic Hybridiation, Molecular Human Reproduction, 10 (4), p. 283-289 (Apr. 2004). cited by applicant Kijak et al., Discrepant Results in the Interpretation of HIV-1 Drug-Resistance Genotypic Data Among Widely Used Algorithms, HIV Medicine, 4 (1), p. 72-78 (Jan. 2003). cited by applicant Kuliev et al., Thirteen Years' Experience on Preimplantation Diagnosis: Report of the Fifth International Symposium on Preimplantation Genetics, Reproductive BioMedicine Online, 8 (2), p. 229-235 (Dec. 22, 2003). cited by applicant Liao et al., Targeted Massively Parallel Sequencing of Maternal Plasma DNA Permits Efficient and Unbiased Detection of Fetal Alleles, Clin Chem, 57(1), p. 92-101 (Jan. 2011). cited by applicant Lo et al., Plasma Placental RNA Allelic Ratio Permits Noninvasive Prenatal Chromosomal Aneuploidy Detection, Nature Medicine, 13(2), p. 218-223 (Feb. 2007). cited by applicant Lo et al., Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the Fetus, Science Translational Medicine, 2(61), p. XX (Dec. 2010). cited by applicant Lun et al., Noninvasive Prenatal Diagnosis of Monogenic Diseases by Digital Size Selection and Relative Mutation Dosage on DNA in Maternal Plasma, PNAS, 105(50), p. 19920-19925 (Dec. 2008). cited by applicant McCray et al., Aggregating UMLS Semantic Types for Reducing Conceptual Complexity, Medinfo2001, 84, p. 216-220 (Jun. 2001). cited by applicant Munne et al., Chromosome Abnormalities in Human Embryos, Textbook of Assisted Reproductive Techniques, p. 355-377 (Jul. 2004). cited by applicant Nannya et al., Robust Algorithm for Copy Number Detection Using High-density Oligonucleotide Single Nucleotide Polymorphism Genotyping Arrays, Cancer Res, 65(14), p. 6071-6079 (Jul. 15, 2005). cited by applicant Ogino et al., Bayesian Analysis and Risk Assessment in Genetic Counseling and Testing, Journal of Molecular Diagnostics, (6) 1, p. 1-9 (Feb. 2004). cited by applicant Page et al., Chromosome Choreography: The Meiotic Ballet, Science, 301, p. 785-789 (Aug. 8, 2003). cited by applicant Perry et al., The Fine-Scale and Complex Architecture of Human Copy-Number Variation, The American Journal of Human Genetics, 82, p. 685-695 (Mar. 2008). cited by applicant Pfaffl, Relative Expression Software Tool (REST©) for Group-Wise Comparison and Statistical Analysis of Relative Expression Results in real-Time PCR, Nucleic Acids Research, 30(9), p. 1-10 (May 1, 2002). cited by applicant Porreca et al., Multiplex Amplification of Large Sets of Human Exons, Nature Methods, 4(11), p. 931-936 (Oct. 2007). cited by applicant Rabinowitz et al., Accurate Prediction of HIV-1 Drug Response from the Reverse Transcriptase and Protease Amino Acid Sequences Using Sparse Models Created by Convex Optimization, Bioinformatics, 22(5), p. 541-549 (Mar. 2006). cited by applicant Rechitsky et al., Preimplantation Genetic Diagnosis with HLA Matching, Reproductive BioMedicine Online, 9 (2), p. 210-221 (Jun. 23, 2004). cited by applicant Renwick et al., Proof of Principle and First Cases Using Preimplantation Genetic Haplotyping—A Paradigm Shift for Embryo Diagnosis, Reproductive BioMedicine Online, 13 (1), p. 110-119 (Apr. 28, 2006). cited by applicant Sander, Genetic Medicine and the Future of Health Care, Science, 287 (5460), p. 1977-1978 (Mar. 17, 2000). cited by applicant Sebat et al., Strong Association of De Novo Copy Number Mutations with Autism, Science, 316, p. 445-449 (Apr. 20, 2007). cited by applicant Sweetkind-Singer, Log-Penalized Linear Regression, International Symposium on Information Theory, p. 286 (Jun. 29-Jul. 4, 2003). cited by applicant Slater et al., High-Resolution Identification of Chromosomal Abnormalities Using Oligonucleotide Arrays Containing 116,204 SNPs, Am. J. Human Genetics, 77 (5), p. 709-726 (Nov. 2005). cited by applicant Stephens, et al., A Comparison of Bayesian Methods for Haplotype Reconstruction from Population Genotype Data, Am. J. Human Genetics, 73 (5), p. 1162-1169 (Nov. 1, 2003). cited by applicant Stevens et al., Ontology-Based Knowledge Representation for Bioinformatics, Briefings in Bioinformatics, 1 (4), p. 398-414 (Nov. 2000). cited by applicant Steyerberg et al., Application of Shrinkage Techniques in Logistic Regression Analysis: A Case Study, Statistical Neerlandica, 55 (1), p. 76-88 (Mar. 2001). cited by applicant Strom et al., Neonatal Outcome of Preimplantation Genetic Diagnosis by Polar Body Removal: the first 109 infants, Pediatrics, (4), p. 650-653 (Oct. 2000). cited by applicant Troyanskaya et al., A Bayesian Framework for Combining Heterogeneous Data Sources for Gene Function Prediction, Proc. Nat. Academy of Sci., 100(14), p. 8348-8353 (Jul. 8, 2003). cited by applicant Tsui et al., Non-Invasive Prenatal Detection of Fetal Trisomy 18 by RNA-SNP Allelic Ratio Analysis Using Maternal Plasma SERPINB2 mRNA: A Feasibility Study, Prenatal Diagnosis, 29(11), 1031-1037 (Nov. 2009). cited by applicant Turner et al., Massively Parallel Exon Capture and Library-Free Resequencing Across 16 Genomes, Nature Methods, 6(5), p. 315-316 (May 2009). cited by applicant Verlinsky et al., Over a Decade of Experience with Preimplantation Genetic Diagnosis, Fertility and Sterility, 82 (2), p. 302-303 (Aug. 2004). cited by applicant Wells, Advances in Preimplantation Genetic Diagnosis, European J. of Obstetrics and Gynecology and Reproductive Biology, 115S, p. S97-S101 (Jul. 1, 2004). cited by applicant Wells, Microarray for Analysis and Diagnosis of Human Embryos, 12th International Congress on Prenatal Diagnosis and Therapy, p. 9-17 (Jun. 24-27, 2004). cited by applicant Wilton, Preimplantation Genetic Diagnosis and Chromosome Analysis of Blastomeres Using Comparative Genomic Hybridization, Hum. Record. Update, (11) 1, p. 33-41 (Jan./Feb. 2005). cited by applicant Yeh et al., Knowledge Acquisition, Consistency Checking and Concurrency Control for Gene Ontology (GO), Bioinformatics, 19(2), p. 241-248 (Jan. 2003). cited by applicant Zhao et al., An Integrated View of Copy Number and Allelic Alterations in the Cancer Genome Using Single Nucleotide Polymorphism Arrays, Cancer Research, 64, p. 3060-3071 (May 1, 2004). cited by applicant European Examination Report in 08 742 125.1 dated Feb. 12, 2010. cited by applicant Extended European Search Report in 06 838 311.6 dated Dec. 30, 2008. cited by applicant PCT International Preliminary Report on Patentability based on PCT/US2006/045281 dated May 27, 2008. cited by applicant PCT International Search Report based on PCT/US2006/045281 dated Sep. 28, 2007. cited by applicant PCT International Search Report based on PCT/US2008/003547 dated Apr. 15, 2009. cited by applicant PCT International Search Report based on PCT/US2009/034506 dated Jul. 8, 2009. cited by applicant PCT International Search Report based on PCT/US2009/045335 dated Jul. 27, 2009. cited by applicant PCT International Search Report based on PCT/US2009/052730 dated Sep. 28, 2009. cited by applicant PCT International Search Report based on PCT/US2010/050824 dated Nov. 15, 2010. cited by applicant PCT International Search Report based on PCT/US11/37018 dated Sep. 27, 2011. cited by applicant Office Action in U.S. Appl. No. 11/004,274 dated May 13, 2008. cited by applicant Office Action in U.S. Appl. No. 11/004,274 dated Feb. 4, 2009. cited by applicant Office Action in U.S. Appl. No. 11/004,274 dated Nov. 24, 2009. cited by applicant Office Action in U.S. Appl. No. 11/004,274 dated Mar. 2, 2011. cited by applicant Office Action in U.S. Appl. No. 11/496,982 dated May 27, 2010. cited by applicant Office Action in U.S. Appl. No. 11/496,982 dated Jan. 21, 2011. cited by applicant Office Action in U.S. Appl. No. 11/634,550 dated Aug. 4, 2010. cited by applicant Office Action in U.S. Appl. No. 11/634,550 dated Jan. 24, 2011. cited by applicant Office Action in U.S. Appl. No. 11/603,406 dated Aug. 19, 2010. cited by applicant Office Action in U.S. Appl. No. 11/603,406 dated Feb. 18, 2011. cited by applicant Office Action in U.S. Appl. No. 12/076,348 dated Aug. 20, 2010. cited by applicant Office Action in U.S. Appl. No. 12/076,348 dated Mar. 4, 2011. cited by applicant Harton et al., “Preimplantation Genetic Testing for Marfan Syndrome”, Molecular Human Reproduction, vol. 2, No. 9, pp. 713-715, Sep. 1996. cited by applicant Myers et al., “Accurate Detection of Aneuploidies in Array CGH and Gene Expression Microarray Data”, Bioinformatics, 2004, 20(18), 3533-3543 (2004). cited by applicant Shaw-Smith et al. “Microarray Based Comparative Genomic Hybridisation (array-CGH) Detects Submicroscopic Chromosomal Deletions and Duplications in Patients with Learning Disability/Mental Retardation and Dysmorphic Features”, J. Med. Genet., Issue 41, pp. 241-248, Apr. 2004. cited by applicant Wilton et al., “Birth of a Healthy Infant After Preimplantation Confirmation of Euploidy by Comparative Genomic Hybridization”, N. Engl. J. Med., vol. 345, No. 21, pp. 1537-1541, Nov. 22, 2001. cited by applicant USPTO Office Action in U.S. Appl. No. 12/076,348 dated Feb. 8, 2013. cited by applicant USPTO Office Action in U.S. Appl. No. 11/603,406 dated Mar. 14, 2013. cited by applicant PCT International Search Report in PCT/US2012/066339 dated Mar. 5, 2013. cited by applicant Wagner et al, “Non-invasive prenatal paternity testing from maternal blood”, Int. J. Legal Med, 123:75-79, Oct. 24, 2008. cited by applicant International Search Report for PCT/US2011/066938 dated Jun. 20, 2012. cited by applicant International Application No. PCT/US2013/028378, International Search Report and Written Opinion dated May 28, 2013, 11 pgs. cited by applicant “Competitive PCR Guide”, TaKaRa Biomedicals, Lit. # L0126 Rev. Aug. 1999, 9 pgs. cited by applicant “Ion AmpliSeq Comprehensive Cancer Panel”, product brochure, Life Technologies Corporation. Retrieved from the Internet “Ion AmpliSeq Designer Provides Full Flexibility to Sequence Genes of Your Choice”, product brochure, Life Technologies Corporation. Retrieved from the Internet “Primer3”, information sheet, Sourceforge.net. [retrieved on Nov. 12, 2012]. Retrieved from the Internet: Agarwal, et al., “Commercial Landscape of Noninvasive Prenatal Testing in the United States”, Prenatal Diagnosis, 33, (2013),521-531. cited by applicant Alkan, et al., “Personalized Copy Number and Segmental Duplication Maps Using Next-Generation Sequencing”, Nature Genetics, vol. 41, No. 10, (Oct. 2009),1061-1068. cited by applicant Allawi, et al., “Thermodynamics of internal C⋅T Mismatches in DNA”, Nucleic Acids Research, vol. 26, No. 11, (1998),2694-2701. cited by applicant Benn, et al., “Non-Invasive prenatal Diagnosis for Down Syndrome: the Paradigm Will Shift, but Slowly”, Ultrasound Obstet. Gynecol., 39, (2012),127-130. cited by applicant Benn, et al., “Non-Invasive Prenatal Testing for Aneuploidy: Current Status and Future Prospects”, Ultrasound Obstet. Gynecol., 42, (2013),15-33. cited by applicant Bermudez, et al., “Single-cell sequencing and mini-sequencing for preimplantation genetic diagnosis”, Prenat Diagn, vol. 23, (2003),669-677. cited by applicant Birch, et al., “Accurate and Robust Quantification of Circulating Fetal and Total DNA in Maternal Plasma from 5 to 41 Weeks of Gestation”, Clinical Chemistry, vol. 51, No. 2, (2005),312-320. cited by applicant Chetty, et al., “Uptake of Noninvasive Prenatal Testing (NIPT) in Women Following Positive Aneuploidy Screening”, Prenatal Diagnosis, 33, (2013),542-546. cited by applicant Dohm, et al., “Substantial Biases in Ultra-Short Read Data Sets From High-Throughput DNA Sequencing”, Nucleic Acids Research, vol. 36, No. 16, e105, (2008),10 pgs. cited by applicant Fan, et al., “Non-Invasive Prenatal Measurement of the Fetal Genome”, Nature, doi:10.1038/nature11251 (with Supplemental Information), (2012),26 pgs. cited by applicant Guichoux, et al., “Current Trends in Microsatellite Genotyping”, Molecular Ecology Resources, 11, (2011),591-611. cited by applicant Hellani, et al., “Multiple displacement amplification on single cell and possible PGD applications”, Molecular Human Reproduction, vol. 10, No. 11, (Oct. 1, 2004),847-852. cited by applicant Johnson, et al., “Comprehensive Analysis of Karyotypic Mosaicism Between Trophectoderm and Inner Cell Mass”, Molecular Human Reproduction, vol. 16, No. 12, (2010),944-949. cited by applicant Johnson, et al., “Preclinical Validation of a Microarray Method for Full Molecular Karyotyping of Blastomeres in a 24-h Protocol”, Human Reproduction, vol. 25, No. 4, (2010),1066-1075. cited by applicant Kaplinski, et al., “MultiPLX: Automatic Grouping and Evaluation of PCR Primers”, Bioinformatics (Advance Access publication), vol. 21, No. 8, (2005),1701-1702. cited by applicant Konfortov, et al., “An Efficient Method for Multi-Locus Molecular Haplotyping”, Nucleic Acids Research, vol. 35, No. 1, e6, (2007),8 pgs. cited by applicant Lathi, et al., “Informatics Enhanced SNP Microarray Analysis of 30 Miscarriage Samples Compared to Routine Cytogenetics”, PLoS ONE, vol. 7, Issue 3, e31282, (Mar. 2012),5 pgs. cited by applicant Leary, et al., “Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome Sequencing”, Science Translational Medicine, vol. 4, Issue 162, (Nov. 28, 2012),12 pgs. cited by applicant Li, et al., “Highly Multiplexed Amplicon Preparation for Targeted Re-Sequencing of Sample Limited Specimens Using the Ion AmpliSeq Technology and Semiconductor Sequencing”, Proceedings of the Annual Meeting of the American Society of Human Genetics [retrieved on Oct. 30, 2012]. Retrieved from the Internet: Li, et al., “Size Separation of Circulatory DNA in Maternal Plasma Permits Ready Detection of Fetal DNA Polymorphisms”, Clinical Chemistry, vol. 50, No. 6, (2004),1002-1011. cited by applicant Lindroos, et al., “Genotyping SNPs by Minisequencing Primer Extension Using Oligonucleotide Microarrays”, Methods in Molecular Biology, vol. 212—Single Nucleotide Polymorphisms: Methods and Protocols, P-K Kwok (ed.), Humana Press, Inc., Totowa, NJ, (2003),149-165. cited by applicant Lo, et al., “Fetal Nucleic Acids in Maternal Blood: the Promises”, Clin. Chem. Lab. Med., vol. 50, No. 6, (2012),995-998. cited by applicant Lo, et al., “Presence of Fetal DNA in Maternal Plasma and Serum”, The Lancet, vol. 350, (Aug. 16, 1997),485-487. cited by applicant Lo, et al., “Quantitative Analysis of Fetal DNA in Maternal Plasma and Serum: Implications for Noninvasive Prenatal Diagnosis”, Am. J. Hum. Genet. 62, (1998),768-775. cited by applicant Lo, et al., “Two-way cell traffic between mother and fetus: biologic and clinical implications”, Blood, vol. 88, No. 11, (Dec. 1, 1996),4390-4395. cited by applicant May, “How Many Species Are There on Earth?”, Science vol. 241, (Sep. 16, 1988),1441-1449. cited by applicant Mennuti, et al., “Is It Time to Sound an Alarm About False-Positive Cell-Free DNA Testing for Fetal Aneuploidy?”, American Journal of Obstetrics, (2013),5 pgs. cited by applicant Mersy, et al., “Noninvasive Detection of Fetal Trisomy 21: Systematic Review and Report of Quality and Outcomes of Diagnostic Accuracy Studies Performed Between 1997 and 2012”, Human Reproduction Update, vol. 19, No. 4, (2013),318-329. cited by applicant Murtaza, et al., “Non-Invasive Analysis of Acquired Resistance to Cancer Therapy by Sequencing of Plasma DNA”, Nature (doi:10.1038/nature12065), (2013),6 pgs. cited by applicant Nicolaides, et al., “Noninvasive Prenatal Testing for Fetal Trisomies in a Routinely Screened First-Trimester Population”, American Journal of Obstetrics (article in press), 207, (2012),1.e1-1.e6. cited by applicant Nicolaides, et al., “Prenatal Detection of Fetal Triploidy from Cell-Free DNA Testing in Maternal Blood”, Fetal Diagnosis and Therapy, (Oct. 10, 2013),1-6. cited by applicant Nicolaides, et al., “Validation of Targeted Sequencing of Single-Nucleotide Polymorphisms for Non-Invasive Prenatal Detection of Aneuploidy of Chromosomes 13, 18, 21, X, and Y”, Prenatal Diagnosis, 33, (2013),575-579. cited by applicant Paez, et al., “Genome coverage and sequence fidelity of φ29 polymerase-based multiple strand displacement whole genome amplification”, Nucleic Acids Research, vol. 32, No. 9, (May 18, 2004),1-11. cited by applicant Palomaki, et al., “DNA Sequencing of Maternal Plasma Reliably Identifies Trisomy 18 and Trisomy 13 as Well as Down Syndrome: an International Collaborative Study”, Genetics in Medicine, (2012),10 pgs. cited by applicant Pertl, et al., “Detection of Male and Female Fetal DNA in Maternal Plasma by Multiplex Fluorescent Polymerase Chain Reaction Amplification of Short Tandem Repeats”, Hum. Genet., 106, (2000),45-49. cited by applicant Rabinowitz, et al., “Non-Invasive Prenatal Aneuploidy Testing of Chromosomes 13, 18, 21, X, and Y Using Targeted Sequencing of Polymorphic Loci”, The American Society of Human Genetics, meeting poster, (2012). cited by applicant Rabinowitz, et al., “Origins and Rates of Aneuploidy in Human Blastomeres”, Fertility and Sterility, vol. 97, No. 2, (Feb. 2012),395-401. cited by applicant Rava, et al., “Circulating Fetal Cell-Free DNA Fraction Differ in Autosomal Aneuploidies and Monosomy X”, Clinical Chemistry (article in press), vol. 60, No. 1, (Sep. 17, 2013),8 pgs. cited by applicant Ryan, et al., “Informatics-Based, Highly Accurate, Noninvasive Prenatal Paternity Testing”, Genetics in Medicine (advance online publication), (Dec. 20, 2012),5 pgs. cited by applicant Samango-Sprouse, et al., “SNP-Based Non-Invasive Prenatal Testing Detects Sex Chromosome Aneuploidies with High Accuracy”, Prenatal Diagnosis, vol. 33, (2013),1-7. cited by applicant Santalucia, Jr., et al., “Improved Nearest-Neighbor Parameters for Predicting DNA Duplex Stability”, Biochemistry, 35, (1996),3555-3562. cited by applicant Santalucia, Jr., et al., “The Thermodynamics of DNA Structural Motifs”, Annu. Rev. Biophys. Biomol. Struct., 33, (2004),415-440. cited by applicant Spits, et al., “Optimization and Evaluation of Single-Cell Whole Genome Multiple Displacement Amplification”, Human Mutation, vol. 27, No. 5, (2006),496-503. cited by applicant Strom, et al., “Three births after preimplantation genetic diagnosis for cystic fibrosis with sequential first and second polar body analysis”, American Journal of Obstetrics and Gynecology, vol. 178, No. 6, (1998),1298-1306. cited by applicant Tang, et al., “Detection of Fetal-Derived Paternally Inherited X-Chromosome Polymorphisms in Maternal Plasma”, Clinical Chemistry vol. 45, No. 11, (1999),2033-2035. cited by applicant Wapner, et al., “Chromosomal Microarray Versus Karyotyping for Prenatal Diagnosis”, The New England Journal of Medicine, vol. 367, No. 23, (Dec. 6, 2012),2175-2184. cited by applicant Watkins, Jr., et al., “Thermodynamic contributions of single internal rA ⋅dA, rC ⋅ dC, rG ⋅ dG and rU ⋅ dT mismatches in RNA/DNA duplexes”, Nucleic Acids Research, vol. 39, No. 5, (Nov. 10, 2010),1894-1902. cited by applicant Wilton, et al., “Birth of a Healthy Infant After Preimplantation Confirmation of Euploidy by Comparative Genomic Hybridization”, N. Engl. J. Med., vol. 345, No. 21, (Nov. 22, 2001),1537-1541. cited by applicant Xia, et al., “Thermodynamic Parameters for an Expanded Nearest-Neighbor Model for Formation of RNA Duplexes with Watson-Crick Base Pairs”, Biochemistry, 37, (1998),14719-14735. cited by applicant Zhou, et al., “Counting Alleles Reveals a Connection Between Chromosome 18q Loss and Vascular Invasion”, Nature Biotechnology, vol. 19, (Jan. 2001),78-81. cited by applicant Zimmermann, et al., “Noninvasive Prenatal Aneuploidy Testing of Chromosomes 13, 18, 21 X, and Y, Using targeted Sequencing of Polymorphic Loci”, Prenatal Diagnosis, 32, (2012),1-9. cited by applicant “Finishing the Euchromatic Sequence of the Human Genome”, Nature vol. 431, (Oct. 21, 2004),931-945. cited by applicant “Genetics Home Reference”, http://ghr.nlm.nih.gov/handbook/genomicresearch/snp, (Feb. 28, 2014),1-2. cited by applicant Ashoor, et al., “Fetal Fraction in Maternal Plasma Cell-Free DNA at 11-13 Weeks' Gestation: Effect of Maternal and Fetal Factors”, Fetal Diagnosis Therapy, (May 4, 2012),1-7. cited by applicant Guerra, et al., “Terminal Contributions for Duplex Oligonucleotide Thermodynamic Properties in the Context of Nearest Neighbor Models”, Biopolymers, vol. 95, No. 3, (2011),194-201. cited by applicant “Nucleic Acids, Linkers and Primers: Random Primers” New England BioLabs 1998/99 Catalog, (1998), 121 and 284. cited by applicant Cairns, “Homozygous Delections of 9p21 in Primary Human Bladder Tumors Detected by Comparative Multiplex Polymerase Chain Reaction”, Cancer Research vol. 54, (1994), 1422-1424. cited by applicant Dieffenbach, “General Concepts for PCR Primer Design”, PCR Methods Appl. vol. 3, (1993), 30-37. cited by applicant Guichoux, “Current Trends in Microsatellite Genotyping”, Molecular Ecology Resources, vol. 11, (2011), 591-611. cited by applicant Hardenbol, “Highly multiplexed molecular inversion probe genotyping: Over 10,000 targeted SNP's genotyped in a singled tube assay”, Genome Research, 15, (2005), 269-275. cited by applicant Hoogendoorn, “Genotyping Single Nucleotide Polymorphisms by Primer Extension and High Performance Liquid Chromatography”, Hum Genet vol. 104, (1999), 89-93. cited by applicant International Application No. PCT/US14/51926, International Search Report dated Dec. 9, 2014, 3 pgs. cited by applicant International Application Serial No. PCT/US14/51926, Written Opinion dated Dec. 9, 2014, 5 pgs. cited by applicant Lo, “Non-Invasive Prenatal Diagnosis by Massively parallel Sequencing of Maternal Plasma DNA, Open Biol 2: 120086, (2012),1-5”. cited by applicant “Multiplexing with RainDrop Digital PCR”, RainDance Technologies Application Note, (2013), 1-2. cited by applicant Perkel, “Overcoming the Challenges of Multiplex PCR”, Biocompare Editorial Article, Oct. 23, 2012, 1-5. cited by applicant Roux, “Optimization and Troubleshooting in PCR”, PCR Methods Appl. vol. 4, (1995), 185-194. cited by applicant Sint, “Advances in Multiplex PCR: Balancing Primer Efficiencies and Improving Detection Success”, Methods in Ecology and Evolution vol. 3, (2012), 898-905. cited by applicant Spiro, “A Bead-Based Method for Multiplexed Identification and Quantitation of DNA Sequences Using Flow Cytometry”, Applied and Environmental Microbiology, Oct. 2000, vol. 66, No. 10, 4258-4265. cited by applicant Wang, “Allele quantification using molecular inversion probes (MIP)”, Nucleic Acids Research, vol. 33, No. 21 , (Nov. 28, 2005), 14 pgs. cited by applicant Wang, “Gestational Age and Maternal Weight Effects on Fetal Cell-Free DNA in Maternal Plasma”, Prenatal Diagnosis, vol. 33, (2013),662-666. cited by applicant Wells, “Detailed Chromosomal and Molecular Genetic Analysis of Single Cells by Whole Genome Amplification and Comparative Genomic Hybridisation”, Nucleic Acids Research, 1999, vol. 27, No. 4, 1214-1218. cited by applicant Wen, “Universal Multiples PCR: A Novel Method of Simultaneous Amplification of Multiple DNA Fragments”, Plant Methods vol. 8, No. 32, (2012), 1-9. cited by applicant Zhang, “Quantifying RNA Allelic Ratios by Microfluidic Multiplex PCR and Sequencing”, Nature Methods, vol. 11, No. 1, Jan. 2014, 51-56. cited by applicant Ashoor, et al., “Chromosome-Selective Sequencing of Maternal Plasma Cell-Free DNA for First-Trimester Detection of Trisomy 21 and Trisomy 18”, American Journal of Obstetrics & Gynecology, 206, (Apr. 2012), 322.e1-322.e5. cited by applicant Brownie, et al., “The Elimination of Primer-Dimer Accumulation in PCR”, Nucleic Acids Research, vol. 25, No. 16, (1997), 3235-3241. cited by applicant Cairns Paul, “Homozygous Deletions of 9p21 in Primary Human Bladder Tumors Detected by Comparative Multiplex Polymerase Chain Reaction”, Cancer Research vol. 54, (1994), 1422-1424. cited by applicant Caliendo Angela, “Multiplex PCR and Emerging Technologies for the Detection of Respiratory Pathogens”, Clinical Infection Diseases vol. 52, Suppl. 4, (2011), S326-S330. cited by applicant Chiu, Rossa W.K., “Effects of Blood-Processing Protocols on Fetal and Total DNA Quantification in Maternal Plasma”, Clinical Chemistry, 47(9), (Jan. 1, 2001), 1607-1613. cited by applicant Cole Neal, “Hyperglycemia-Induced Membrane Lipid Peroxidation and Elevated Homocysteine Levels Are Poorly Attenuated by Exogenous Folate in Embryonic Chick Brains”, Comparative Biochemistry and Physiology, Part B, vol. 150, (2008), 338-343. cited by applicant D'Aquila, et al., “Maximizing Sensitivity and Specificity of PCR by Pre-Amplification Heating”, Nucleic Acids Research, vol. 19, No. 13, (1991), 3749. cited by applicant De Vries et al., “Diagnostic genome profiling in mental retardation”, Am J Hum Genet, 77, p. 606-616, published online Aug. 30, 2005 (Aug. 30, 2005). cited by applicant Dieffenbach C, “General Concepts for PCR Primer Design”, PCR Methods Appl. vol. 3, (1993), 30-37. cited by applicant Dolganov, et al., “A Novel Method of Gene Transcript Profiling in Airway Biopsy Homogenates Reveals Increased Expression of a Na +—K+—CL-Contransporter (NKCC1) in Asthmatic Subjects”, Genome Res. 2001, vol. 11, (2001), 1473-1483. cited by applicant Donohoe G, et al., “Rapid Single-Tube Screening of the C282Y Hemochromatosis Mutation by Real-Time Multiplex Allele-specific PCR without Fluorescent Probes”, Clinical Chemistry, 2000, 46: 1540-1547. cited by applicant Fan, “Highly Parallel Genomic Assay”, Nature Reviews, vol. 7, Aug. 2006, 632-644. cited by applicant Fazio, et al., “Identification of RAPD Markers Linked to Fusarium Crown and Root Rot Resistance (Frl) in Tomato”, Euphytica 105, (Mar. 1, 1999), 205-210. cited by applicant Finishing the Euchromatic Sequence of the Human Genome, Nature vol. 431, (Oct. 21, 2004), 931-945. cited by applicant Frost Mackenzie, “Differential Effects of Chronic Pulsatile Versus Chronic Constant Maternal Hyperglycemia on Fetal Pancreatic B-Cells”, Journal of Pregnancy, vol. 2012, Article ID 812094, 8 pgs. cited by applicant Genetics Home Reference, http://ghr.nlm.nih.gov/handbook/genomicresearch/snp, (Feb. 28, 2014), 1-2. cited by applicant Hara, et al., “Subtractive cDNA Cloning Using Oligo(dT)30-latex and PCR: Isolation of cDNA Clones Specific to Undifferentiated Human Embryonal Carcinoma Cells”, Nucleic Acids Research, vol. 19, No. 25, (1991), 7097-7104. cited by applicant Hardenbol, et al., “Multiplexed Genotyping With Sequence-Tagged Molecular Inversion Probes”, Nature Biotechnology vol. 21, No. 6, (Jun. 2003), 673-678. cited by applicant Hardenbol, et al., “Highly multiplexed molecular inversion probe genotyping: Over 10,000 targeted SNP's genotyped in a singled tube assay”, Genome Research, 15, (Jan. 1, 2005), 269-275. cited by applicant Hoogendoorn Bastiaan, “Genotyping Single Nucleotide Polymorphisms by Primer Extension and High Performance Liquid Chromatography”, Hum Genet vol. 104, (1999), 89-93. cited by applicant How Many Carbs in a Potato?, [Online]. Retrieved from the Internet: Ido Yasuo, “Hyperglycemia-Induced Apoptosis in Human Umbilical Vein Endothelial Cells: Inhibition by the AMP-Activated Protein Kinase Activation”, Diabetes, vol. 51, Jan. 2002, 159-167. cited by applicant International Application No. PCT/US2013/57924, International Search Report and Written Opinion dated Feb. 18, 2014, 8 pgs. cited by applicant Liew et al. Clinical Chemistry, 2004, 50(7), 1156-1164. cited by applicant Lo, “Non-Invasive Prenatal Diagnosis by Massively parallel Sequencing of Maternal Plasma DNA”, Open Biol 2: 120086, (2012), 1-5. cited by applicant Miller Robert, “Homocysteine-Induced Changes in Brain Membrane Composition Correlate with Increased Brain Caspase-3 Activities and Reduced Chick Embryo Viability”, Comparative Biochemistry and Physiology, Part B, vol. 136 (2003), 521-532. cited by applicant Miller Robert, “Hyperglycemia-Induced Changes in Hepatic Membrane Fatty Acid Composition Correlate with Increased Caspase-3 Activities and Reduced Chick Embryo Viability”, Comparative Biochemistry and Physiology, Part B, vol. 141 (2005), 323-330. cited by applicant Multiplexing with RainDrop Digital PCR, RainDance Technologies Application Note, (2013), 1-2. cited by applicant Nucleic Acids, Linkers and Primers: Random Primers, New England BioLabs 1998/99 Catalog, (1998), 121 and 284. cited by applicant Palomaki, et al., “DNA Sequencing of Maternal Plasma Reliably Identifies Trisomy 18 and Trisomy 13 as Well as Down Syndrome: an International Collaborative Study”, Genetics in Medicine, (2012), 10 pgs. cited by applicant Perkel Jeffrey, “Overcoming the Challenges of Multiplex PCR”, Biocompare Editorial Article, Oct. 23, 2012, 1-5. cited by applicant Podder et al. (BMC Med Genom, 2008, vol. 1, No. 5, p. 1 of 15). cited by applicant Rahmann, et al., “Mean and Variance of the Gibbs Free Energy of Oligonucleotides in the Nearest neighbor Model Under Varying Conditions”, Bioinformatics, vol. 20, No. 17, (2004), 2928-2933. cited by applicant Renwick, et al., “Proof of Principle and First Cases Using Preimplantation Genetic Haplotyping—A Paradigm Shift for Embryo Diagnosis”, Reproductive BioMedicine Online, vol. 13, No. 1, (2006), 110-119. cited by applicant Ricciotti Hope, “Eating by Trimester”, [Online]. Retrieved from Internet:<http://www.youandyourfamily.com/article.php?story=Eating+by+Trimester>, (Oct. 7, 2014), 3 pgs. cited by applicant Roux K, “Optimization and Troubleshooting in PCR”, PCR Methods Appl. vol. 4, (1995), 185-194. cited by applicant Rozen, et al., “Primer3 on the WWW for General Users and for Biologist Programmers”, Methods in Molecular Biology, vol. 132: Bioinformatics Methods and Protocols, (1999),365-386. cited by applicant Russell, et al., “X Chromosome Loss and Ageing”, Cytogenet Genome Res, vol. 116, (2007),181-185. cited by applicant Schoumans et al., “Detection of chromosomal imbalances in children with idiopathic mental retardation by array based comparative genomic hybridisation (array-CGH)”, JMed Genet, 42, p. 699-705, Sep. 2005 (Sep. 2005). cited by applicant Sherlock, et al., “Assessment of Diagnostic Quantitative Fluorescent Multiplex Polymerase Chain Reaction Assays Performed on Single Cells,” Annals of Human Genetics, 1998, vol. 62 (1), pp. 9-23. cited by applicant Sint Daniela, “Advances in Multiplex PCR: Balancing Primer Efficiencies and Improving Detection Success”, Methods in Ecology and Evolution vol. 3, (2012), 898-905. cited by applicant Snijders, et al., “Assembly of Microarrays for Genome-Wide Measurement of DNA Copy Number”, Nature Genetics vol. 29, (Nov. 2001), 263-264. cited by applicant Tong, “Noninvasive Prenatal Detection of Fetal Trisomy 18 by Epigenetic Allelic Ratio Analysis in Maternal Plasma: Theoretical and Empirical Considerations”, Clinical Chemistry vol. 52, No. 12, (2006), 2194-2202. cited by applicant U.S. Appl. No. 11/634,550, Office Action dated Jan. 24, 2011, 13 pgs. cited by applicant U.S. Appl. No. 13/683,604, Office Action dated Nov. 22, 2013, 81pages. cited by applicant Vallone, et al., “AutoDimer: a Screening Tool for Primer-Dimer and Hairpin Structures”, BioTechniques vol. 37, (Aug. 2004), 226-231. cited by applicant Wagner, Jasenka et al. “Non-invasive prenatal paternity testing from maternal blood”, International Journal of Legal Medicine, Springer, Berlin, DE, vol. 123, No. 1, Oct. 24, 2008 (Oct. 24, 2008), pp. 75-79. cited by applicant Wang, et al., “Gestational Age and Maternal Weight Effects on Fetal Cell-Free DNA in Maternal Plasma”, Prenatal Diagnosis, vol. 33, (2013), 662-666. cited by applicant Wang, et al., Yuker, “Allele quantification using molecular inversion probes (MIP)”, Nucleic Acids Research, vol. 33, No. 21, (Nov. 28, 2005), 14 pgs. cited by applicant Wells Dagan, “Detailed Chromosomal and Molecular Genetic Analysis of Single Cells by Whole Genome Amplification and Comparative Genomic Hybridisation”, Nucleic Acids Research, 1999, vol. 27, No. 4, 1214-1218. cited by applicant Wen Daxing, “Universal Multiples PCR: A Novel Method of Simultaneous Amplification of Multiple DNA Fragments”, Plant Methods vol. 8, No. 32, (2012), 1-9. cited by applicant Zhang Rui, “Quantifying RNA Allelic Ratios by Microfluidic Multiplex PCR and Sequencing”, Nature Methods, vol. 11, No. 1, Jan. 2014, 51-56. cited by applicant European Application No. 014198110, European Search Report dated Apr. 28, 2015, 3 pages. cited by applicant “Blast of AAAAAAAAATTTAAAAAAAATTT(http://blast.ncbi.nlm.nih.gov/Blast.cgi, downloaded May 4, 2015)”, May 4, 2015. cited by applicant “db SNP rs2056688 (http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2056688, downloaded May 4, 2015”, 2015. cited by applicant “Declaration by Dr. Zimmerman of Oct. 30, 2014 filed in U.S. Appl. No. 14/044,434”, Oct. 30, 2014. cited by applicant “Merriam-Webster.com (http://www.merriam-webster.com/dictionary/universal, downloaded Jul. 23, 2014)”, Jul. 23, 2014. cited by applicant “NucleicAcids, Linkers and Primers: Random Primers”, New England BioLabs 1998/99Catalog, 1998, 121 and 284. cited by applicant “www.fatsecret.com (printed from internet Nov. 1, 2014)”, Nov. 1, 2014. cited by applicant Bentley, David R et al., “Accurate Whole Human Genome Sequencing Using Reversible Terminator Chemistry”, Nature, 456, 6, 2008, 53-59. cited by applicant Bianchi, D W. et al., “Fetal gender and aneuploidy detection using fetal cells maternal blood: analysis of NIFTY I data”, Prenat Diagn 2002; 22, 2002, 609-615. cited by applicant Cross, Jillian et al., “Resolution of trisomic mosaicism in prenatal diagnosis: estimated performance of a 50K SNP microarray”, Prenat Diagn 2007; 27, 2007, 1197-1204. cited by applicant Ding, C et al., “Direct molecular haplotyping of long-range genomic DNA with M1-PCR”, PNAS 100(13), 2003, 7449-7453. cited by applicant Dolganov, Gregory et al., “A Novel Method of Gene Transcript Profiling in Airway Biopsy Homogenates Reveals Increased Expression of a Na—K+—Cl-Cotransporter (NKCC1) in Asthmatic Subjects”, Genome Res.,11, 2001, 1473-1483. cited by applicant Fan, et al., “Whole-genome molecular haplotyping of single cells”, Nature Biotechnology, vol. 29, No. 1, Jan. 1, 2011, 51-57. cited by applicant Forejt, et al., “Segmental trisomy of mouse chromosome 17: introducing an alternative model of Down's syndrome”, Genomics, 4(6), 2003, 647-652. cited by applicant Handyside, et al., “Isothermal whole genome amplification from single and small numbers of cells: a new era for preimplantation genetic diagnosis of inherited disease”, Molecular Human Reproduction vol. IO, No. 10 pp. 767-772, 2004. cited by applicant Hardenbol, Paul et al., “Highly multiplexed molecular inversion probe genotyping: Over 10,000 targeted SNPs genotyped in a singled tube assay”, Genome Research, 15, 2005, 269-275. cited by applicant Harismendy, O et al., “Method for Improving Sequence Coverage Uniformity of Targeted Genomic Intervals Amplified by LR-PCR Using Illumina GA Sequencing-By-Synthesis Technology”, Bio Techniques, 46(3), 2009, 229-231. cited by applicant Howie, et al., “Fast and accurate genotype imputation in genome-wide association studies through pre-phasing”, Nature Genetics, voi. 44, No. 8, Jul. 22, 2012, 955-959. cited by applicant Illumina Catalog, “Paired-End Sample Preparation Guide, Illumina Catalog# PE-930-1 001, Part# 1005063 Rev. E”, 2011, 1-40. cited by applicant Lo, “Non-Invasive Prenatal Diagnosis by Massively parallel Sequencing of Maternal Plasma DNA”, Open Biol 2: 120086, 2012, 1-5. cited by applicant Lo, et al., “Prenatal Sex Determination by DNA Amplification from Maternal Peripheral Blood”, The Lancet,2, 8676, 1989, 363-1365. cited by applicant PCT/US2014/051926, , “International Search Report”, dated Dec. 9, 2014, 3 pgs. cited by applicant Price, T.S. et al., ““SW-ARRAY: a dynamic programming solution for the identification of copy-number changes in genomic DNA using array comparative genome hybridization data”,”, Nucleic Acids Research, vol. 33, No. 11, Jun. 16, 2005 (Jun. 16, 2005), pp. 3455-3464. cited by applicant Roux, K , “Optimization and Troubleshooting in PCR”, PCR Methods Appl. 4, 1995, 185-194. cited by applicant Rozen, Steve et al., “Primer3 on the WWW for General Users and for Biologis Programmers”, Methods in Molecular Biology, 132: Bioinformatics Methods and Protocols, 1999, 365-386. cited by applicant Ryan, et al., “The importance of phase information for human genomics”, Nature Reviews Genetics, voi. 12, No. 3, Mar. 1, 2011. cited by applicant Rychlik, et al., “Optimization of the annealing temperature for DNA amplification in vitro”, Nucleic Acids Research, 18(21), 1990, 6409-6412. cited by applicant Sermon, Karen et al., “Preimplantation genetic diagnosis”, The Lancet, Lancet Limited. 363(9421), 2000, 1633-1641. cited by applicant Sint, Daniela et al., “Advances in Multiplex PCR: Balaning Primer Efficiencies and Improving Detection Success”, Methods in Ecology and Evolution, 3, 2012, 898-905. cited by applicant Su, S.Y. et al., ““Inferring combined CNV/SNP haplotypes from genotype data””, Bioinformatics, vol. 26, No. 11,1, Jun. 1, 2010, 1437-1445. cited by applicant Sun, Guihua et al., “SNPs in human miRNA genes affect biogenesis and function”, RNA, 15(9), 2009, 1640-1651. cited by applicant Varley, Katherine Elena et al., “Nested Patch PCR Enables Highly Multiplexed Mutation Discovery in Candidate Genes”, Genome Res., 18(11), 2008, 1844-1850. cited by applicant Wang, Hui-Yun et al., “A genotyping system capable of simultaneously analyzing >1000 single nucleotide polymorphisms in a haploid genome”, Genome Res., 15, 2005, 276-283. cited by applicant Wapner, R. et al., “Chromosomal Microarray Versus Karyotyping for Prenatal Diagnosis”, The New England Journal of Medicine, 367 (23), 2012, 2175-2184. cited by applicant Wilton, L., “Preimplantation Genetic Diagnosis and Chromosome Analysis of Blastomeres Using Comparative Genomic Hybridization”, Human Reproduction Update, 11 (1), 2005, 33-41. cited by applicant Morand, et al., “Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers”, Am J Clin Nutr. Jan. 2011;93(1 ):73-80. Epub Nov. 10, 2010. cited by applicant Ellison, Aaron M. , “Bayesian Inference in Ecology”, Ecology Letters, 2004, vol. 7, p. 509-520. cited by applicant Fredriksson, et al., “Multiplex amplification of all coding sequences within 10 cancer genes by Gene-Collector”, Nucleic Acids Research, 2007, vol. 35, No. 7 e47, 1-6. cited by applicant Holleley, et al., “Multiplex Manager 1.0: a Cross-Platform Computer Program that Plans and Optimizes Multiplex PCR”, BioTechniques46:511-517 (Jun. 2009), 511-517. cited by applicant Hospital, F et al., “A General Algorithm to Compute Multilocus Genotype Frequencies Under Various Mating Systems” vol. 12, No. 6, Jan. 1, 1996 (Jan. 1, 1996), pp. 455-462. cited by applicant Krjutskov, K et al., “Development of a single tube 640-plex genotyping method for detection of nucleic acid variations on microarrays”, Nucleic Acids Research, vol. 36, No. 12, May 23, 2008 (May 23, 2008), pp. e75-e75. cited by applicant Markoulatos, P et al., “Multiplex Polymerase Chain Reaction: A Practical Approach”, 2002 Wiley-Liss, Inc. DOI 10.1002/jcla.2058 Journal of Clinical Laboratory Analysis 16:47-51 (2002). cited by applicant Muse, Spencer V. , “Examining rates and patterns of nucleotide substitution in plants”, Plant Molecular Biology 42: 25-43, 2000. cited by applicant Servin, B et al., “MOM: A Program to Compute Fully Informative Genotype Frequencies in Complex Breeding Schemes”, Journal of Heredity, vol. 93, No. 3, Jan. 1, 2002 (Jan. 1, 2002), pp. 227-228. cited by applicant Shen, et al., “High-quality DNA sequence capture of 524 disease candidate genes”, High-quality DNA sequence capture of 524 disease candidate genes, Proceedings of the National Academy of Sciences, vol. 108, No. 16, Apr. 5, 2011 (Apr. 5, 2011), pp. 6549-6554. cited by applicant Shen, Zhiyong, “MPprimer: a program for reliable multiplex PCR primer design”, BMC Bioinformatics 2010, 11:143, 1-7. cited by applicant Tamura, et al., “Sibling Incest and formulation of paternity probability: case report”, Legal Medicine, 2000, vol. 2, p. 189-196. cited by applicant Tang, et al., Multiplex fluorescent PCR for noninvasive prenatal detection of fetal-derived paternally inherited diseases using circulatory fetal DNA in maternal plasma, Eur J Obstet Gynecol Reprod Biol, 2009, v.144, No. 1, p. 35-39. cited by applicant You, Frank M. et al., “BatchPrimer3: A high throughput web application for PCR and sequencing primer design”, BMC Bioinformatics, Biomed Central, London, GB, vol. 9, No. 1, May 29, 2008 (May 29, 2008), p. 253. cited by applicant “Guideline related to genetic examination”, Societies Related to Genetic Medicine, Japanese Society for Genetic Counseling, Japanese Society for Gene Diagnosis and Therapy, Japan Society of Obstetrics, 2003, 2-15. cited by applicant Aoki, Yasuhiro, “Statistical and Probabilistic Bases of Forensic DNA Testing”, The Journal of the Iwate Medical Association, 2002, vol. 54, 81-94. cited by applicant Kinnings, S. L. et al., “Factors affecting levels of circulating cell-free fetal DNA in maternal plasma and their implications for noninvasive prenatal testing”, Prenatal Diagnosis, vol. 35, 2015, 816-822. cited by applicant Sasabe, Yutaka, “Genetic Diagnosis of Gametes and Embryos Resulting from ART”, Japanese Journal of Fertility and Sterility, 2001, vol. 46, No. 1, 43-46. cited by applicant Kirkizlar, E. et al., “Detection of Clonal and Subclonal Copy-Number Variants in Cell-Free DNA from Patients with Breast Cancer Using a Massively Multiplexed PCR Methodology”, Translational Oncology, vol. 8, No. 5, Oct. 2015, pp. 407-416. cited by applicant Riley, D. E., “DNA Testing: An Introduction for Non-Scientists an Illustrated Explanation”, Scientific Testimony: An Online Journal, http://www.scientific.org/tutorials/articles/riley/riley.html, Apr. 6, 2005, 22 pages. cited by applicant Tu, J. et al., “Pair-barcode high-throughput sequencing for large-scale multiplexed sample analysis”, BMC Genomics, vol. 13, No. 43, Jan. 25, 2012, 1-9. cited by applicant PCT/US2015/026957, “International Preliminary Report on Patentability dated Nov. 3, 2016”, Nov. 3, 2016, 3 pages. cited by applicant Rachlin, J. et al., “Computational tradeoffs in multiplex PCR assay design for SNP genotyping”, BMC Genomics, vol. 6, No. 102, Jul. 25, 2005, 11 pages. cited by applicant “Random variable”, In the Penguin Dictionary of Mathematics. Retrieved from http:/ /www.credoreference.com/entry/penguinmath/random_variable, 2008, 1 page. cited by applicant Casbon, J. A. et al., “A method for counting PCR template molecules with application to next-generation sequencing”, Nucleic Acids Research, vol. 39, No. 12, Apr. 13, 2011, 1-8. cited by applicant Craig, D. W. et al., “Identification of genetic variants using bar-coded multiplexed sequencing”, Nature Methods, vol. 5, Oct. 2008, 887-893. cited by applicant Fan, H. Christina et al., “Sensitivity of Noninvasive Prenatal Detection of Fetal Aneuploidy from Maternal Plasma Using Shotgun Sequencing Is Limited Only by Counting Statistics”, PLoS ONE, vol. 5, Issue 5 (e10439), May 3, 2010, 1-6. cited by applicant Fu, G. K. et al., “Counting individual DNA molecules by the stochastic attachment of diverse labels”, PNAS, vol. 108, No. 22, May 31, 2011, 9026-9031. cited by applicant Fu, G. K. et al., “Digital Encoding of Cellular mRNAs Enabling Precise and Absolute Gene Expression Measurement by Single-Molecule Counting”, Analytical Chemistry, vol. 86, Mar. 3, 2014, 2867-2870. cited by applicant Hollas, B. et al., “A stochastic approach to count RN A molecules using DNA sequencing methods”, Lecture Notes in Computer Science, vol. 2812, 2003, 55-62. cited by applicant Hug, H. et al., “Measurement of the Number of molecules of a single mRNA species in a complex mRNA preparation”, J. Theor. Biol., vol. 221, 2003, 615-624. cited by applicant Hultin, E. et al., “Competitive enzymatic reaction to control allele-specific extensions”, Nucleic Acids Research, vol. 33, No. 5, Mar. 14, 2005, 1-10. cited by applicant Jabara, C. B. et al., “Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID”, PNAS, vol. 108, No. 50, Dec. 13, 2011, 20166-20171. cited by applicant Kinde, I. et al., “Detection and quantification of rare mutations with massively parallel sequencing”, PNAS, vol. 108, No. 23, Jun. 7, 2011, 9530-9535. cited by applicant Kivioja, T. et al., “Counting absolute numbers of molecules using unique molecular identifiers”, Nature Methods, Advance Online Publication, Nov. 20, 2011, 1-5. cited by applicant McCloskey, M. L. et al., “Encoding PCR Products with Batch-stamps and Barcodes”, Biochem Genet., vol. 45, Oct. 23, 2007, 761-767. cited by applicant Merriam-Webster, “Medical Definition of Stimulant”, http://www.merriam-webster.com/medical/stimulant, Mar. 14, 2016, 7 pages. cited by applicant Miner, B. E. et al., “Molecular barcodes detect redundancy and contamination in hairpin-bisulfite PCR”, Nucleic Acids Research, vol. 32, No. 17, Sep. 30, 2004, 1-4. cited by applicant Munne, S. et al., “Chromosome Abnormalities in Human Embryos”, Textbook of Assisted Reproductive Techniques, 2004, pp. 355-377. cited by applicant Ragoussis, J., “Genotyping Technologies for Genetic Research”, Annual Review of Genomics and Human Genetics, vol. 10 (1), Sep. 1, 2009, 117-133. cited by applicant Schmitt, M. W. et al., “Detection of ultra-rare mutations by next-generation sequencing”, PNAS, vol. 109, No. 36, Sep. 4, 2012, 14508-14513. cited by applicant Shiroguchi, K. et al., “Digital RNA sequencing minimizes sequence-dependent bias and amplification noise with optimized single-molecule barcodes”, PNAS, vol. 109, No. 4, Jan. 24, 2012, 1347-1352. cited by applicant Taliun, D. et al., “Efficient haplotype block recognition of very long and dense genetic sequences”, BMC Bioinformatics, vol. 15 (10), 2014, 1-18. cited by applicant Abbosh, C. et al., “Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution”, Nature, vol. 545, May 25, 2017, 446-451. cited by applicant Carvalho, B. et al., “Exploration, normalization, and genotype calls of high-density oligonucleotide SNP array data”, Biostatistics, vol. 8, No. 2, 2007, 485-499. cited by applicant De Bruin, E. et al., “Spatial and temporal diversity in genomic instability processes defines lung cancer evolution”, Science, vol. 346, No. 6206, Oct. 10, 2014, 251-256. cited by applicant Jamal-Hanjani, M. et al., “Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancer”, Annals of Oncology, vol. 27, No. 5, Jan. 28, 2016, 862-867. cited by applicant Jamal-Hanjani, M. et al., “Tracking Genomic Cancer Evolution for Precision Medicine: The Lung TRACERx Study”, PLOS Biology, vol. 12, No. 7, Jul. 2014, 1-7. cited by applicant Narayan, A. et al., “Ultrasensitive measurement of hotspot mutations in tumor DNA in blood using error-suppressed multiplexed deep sequencing”, Cancer Research, vol. 72, No. 14, Jul. 15, 2012, 3492-3498. cited by applicant Rogaeva, E. et al., “The Solved and Unsolved Mysteries of the Genetics of Early-Onset Alzheimer's Disease”, NeuroMolecular Medicine, vol. 2, 2002, 1-10. cited by applicant Thermofisher Scientific, “Ion AmpliSeq Cancer Hotspot Panel v2”, Retrieved from the Internet: https://tools.thermofisher.com/content/sfs/brochures/Ion-AmpliSeq-Cancer-Hotspot-Panel-Flyer.pdf, 2015, 2 pages. cited by applicant Wapner, R. et al., “First-Trimester Screening for Trisomies 21 and 18”, The New England Journal of Medicine, vol. 349, No. 15, Oct. 9, 2003, 1405-1413. cited by applicant Xu, S. et al., “Circulating tumor DNA identified by targeted sequencing in advanced-stage non-small cell lung cancer patients”, Cancer Letters, vol. 370, 2016, 324-331. cited by applicant Chang, H.W. et al., “Assessment of Plasma DNA Levels, Allelic Imbalance, and CA 125 as Diagnostic Tests for Cancer”, Journal of the National Cancer Institute, vol. 94, No. 22, Nov. 20, 2002, 1697-1703. cited by applicant Ford, E. et al., “A method for generating highly multiplexed ChIP-seq libraries”, BMC Research Notes, vol. 7, No. 312, May 22, 2014, 1-5. cited by applicant Garcia-Murillas, I. et al., “Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer”, Science Translational Medicine, vol. 7, No. 302, Aug. 26, 2015, 1-2. cited by applicant Jamal-Hanjani, M. et al., “Tracking the Evolution of Non-Small-Cell Lung Cancer”, The New England Journal of Medicine, vol. 376, No. 22, Jun. 1, 2017, 2109-2121. cited by applicant Kim, H. et al., “Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution”, Genome Research, vol. 25, No. 3, Feb. 3, 2015, 316-327. cited by applicant Leary, R. J. et al., “Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing”, Science Translational Medicine, vol. 2, No. 20, Feb. 24, 2010, 1-8. cited by applicant Ma, Xiaotu et al., “Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia”, Nature Communications, vol. 6, Mar. 19, 2015, 1-12. cited by applicant Margulies, M. et al., “Genome sequencing in microfabricated high-density picolitre reactors”, Nature, vol. 437, Sep. 15, 2005, 376-380. cited by applicant McBride, D. et al., “Use of Cancer-Specific Genomic Rearrangements to Quantify Disease Burden in Plasma from Patients with Solid Tumors”, Genes, Chromosomes & Cancer, vol. 49, Aug. 19, 2010, 1062-1069. cited by applicant Pergament, E. et al., “Single-Nucleotide Polymorphism-Based Noninvasive Prenatal Screening in a High-Risk and Low-Risk Cohort”, Obstetrics & Gynecology, vol. 124, No. 2, Part 1, Aug. 2014, 210-218 + Appendices. cited by applicant Popova, T. et al., “Genome Alteration Print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arrays”, Genome Biology, vol. 10, R128, Nov. 11, 2009, 1-14. cited by applicant Primdahl, H. et al., “Allelic Imbalances in Human Bladder Cancer: Genome-Wide Detection With High-Density Single-Nucleotide Polymorphism Arrays”, Journal of the National Cancer Institute, vol. 94, No. 3, Feb. 6, 2002, 216-223. cited by applicant Samango Sprouse, C. et al., “SNP-based non-invasive prenatal testing detects sex chromosome aneuploidies with high accuracy”, Prenatal Diagnosis, vol. 33, 2013, 643-649. cited by applicant Butler, J. et al., “The Development of Reduced Size STR Amplicons as Tools for Analysis of Degraded DNA*”, Journal of Forensic Sciences, vol. 48, No. 5, 2003, 1054-1064. cited by applicant Fan, H. C. et al., “Microfluidic digital PCR enables rapid prenatal diagnosis of fetal aneuploidy”, American Journal of Obstetrics & Gynecology, vol. 200, May 2009, 543.e1-543.e7. cited by applicant Hawkins, T. et al., “Whole genome amplification—applications and advances”, Current Opinion in Biotechnology, 13, 2002, 65-67. cited by applicant Pathak, A. et al., “Circulating Cell-Free DNA in Plasma/Serum of Lung Cancer Patients as a Potential Screening and Prognostic Tool”, Clinical Chemistry, 52, 2006, 1833-1842. cited by applicant Sahota, A., “Evaluation of Seven PCR-Based Assays for the Analysis of Microchimerism”, Clinical Biochemistry, vol. 31, No. 8., 1998, 641-645. cited by applicant Ten Bosch, J., “Keeping Up With the Next Generation Massively Parallel Sequencing in Clinical Diagnostics”, Journal of Molecular Diagnostics, vol. 10, No. 6, 2008, 484-492. cited by applicant Wikipedia, “Maximum a posteriori estimation”, https://en.wikipedia.org/w/index.php?title=Maximum_a_posteriori_estimation&oldid=26878808, [retrieved on Aug. 1, 2017], Oct. 30, 2005, 2 pages. cited by applicant Wright, C. et al., “The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis”, Human Reproduction Update, vol. 15, No. 1, 2009, 139-151. cited by applicant Xu, N. et al., “A Mutation in the Fibroblast Growth Factor Receptor 1 Gene Causes Fully Penetrant Normosmic Isolated Hypogonadotropic Hypogonadism”, The Journal of Clinical Endocrinology & Metabolism, vol. 92, No. 3, 2007, 1155-1158. cited by applicant Zhong, X. et al., “Risk free simultaneous prenatal identification of fetal Rhesus D status and sex by multiplex real-time PCR using cell free fetal DNA in maternal plasma”, Swiss Medical Weekly, vol. 131, Mar. 2001, 70-74. cited by applicant Cansar, “Hs-578-T—Copy Number Variation—Cell Line Synopsis”, ICR Cancer Research UK, Retrieved on Mar. 26, 2018 from https://cansar.icr.ac.uk/cansar/cell-lines/Hs-578-T/copy_number_variation/chromosome_8/, Mar. 26, 2018, 50 pgs. cited by applicant Choi, M. et al., “Genetic diagnosis by whole exome capture and massively parallel DNA sequencing”, PNAS, vol. 106, No. 45, Nov. 10, 2009, 19096-19101. cited by applicant Jahr, S. et al., “DNA Fragments in the Blood Plasma of Cancer Patients: Quantitations and Evidence for Their Origin from Apoptotic and Necrotic Cells”, Cancer Research, vol. 61, Feb. 15, 2001, 1659-1665. cited by applicant Jarvie, T., “Next generation sequencing technologies”, Drug Discovery Today: Technologies, vol. 2, No. 3, 2005, 255-260. cited by applicant Margulies, M. et al., “Genome sequencing in microfabricated high-density picolitre reactors plus Supplemental Methods”, Nature, vol. 437, Sep. 15, 2005, 40 pgs. cited by applicant Ohsawa, M. et al., “Prenatal Diagnosis of Two Pedigrees of Fukuyama Type Congenital Muscular Dystrophy by Polymorphism Analysis”, The Health and Welfare Ministry, 1994, 5 pgs. cited by applicant Merriam-Webster (attached, available at http://www.merriam-webster.com/medical/stimulant, accessed Mar. 14, 2016). cited by applicant PRNewswire (Research Suggests Daily Consumption of Orange Juice Can Reduce Blood Pressure and May Provide Beneficial Effects to Blood Vessel Function: New Study Identified Health Benefits in Orange Juice, Dec. 8, 2010). cited by applicant The Bump (Panorama Test, attached, Jul. 1, 2013). cited by applicant What to Expect (Weird Harmony results, attached, May 1, 2015). cited by applicant Wikipedia (attached, available at https://en.wikipedia.org/wiki/Stimulant, accessed Mar. 14, 2016). cited by applicant Hall, M., “Panorama Non-Invasive Prenatal Screening for Microdeletion Syndromes”, Apr. 1, 2014 (Apr. 1, 2014), XP055157224, Retrieved from the Internet: URL:http://www.panoramatest.com/sites/default/files/files/PanoramaMicrodeletionsWhite Paper-2.pdf [retrieved on Dec. 8, 2014]. cited by applicant Bevinetto, Gina, Bevinetto (5 Foods All Pregnant Women Need, American Baby, available at http://www.parents.com/pregnancy/mybody/nutrition/5greatpregnancyfoods/, Apr. 15, 2008). cited by applicant Dieffenbach, C W. et al., “General concepts for PCR primer design”, Genome Research. PCR methods and Applications vol. 3, 1993, S30-S37. cited by applicant Echeverri, et al., “Caffeine's Vascular Mechanisms of Action”, International Journal of Vascular Medicine vol. 2010(2010), 10 pages, Aug. 25, 2010. cited by applicant Forshew, et al., “Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA”, Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci. Transl. Med. 4, 136 30 (2012)., 1-12. cited by applicant Hayden, et al., “Multiplex-Ready PCR: A new method for multiplexed SSR and SNP genotyping”, BMC Genomics 2008, 9(80), 1-12. cited by applicant Ishii, et al., “Optimization of Annealing Temperature to Reduce Bias Caused by a Primer Mismatch in Multitemplate PCR”, Applied and Environmental Microbiology, Aug. 2001, p. 3753-3755. cited by applicant Liao, J. et al., “An Alternative Linker-Mediated Polymerase Chain Reaction Method Using a Dideoxynucleotide to Reduce Amplification Background”, Analytical Biochemistry 253, 137-139 (1997). cited by applicant Morand, et al., “Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers”, Am J Clin Nutr. Jan. 2011;93(1 ):73-80. Epub 2010 Nov. 10. cited by applicant Nygren, et al., “Quantification of Fetal DNA by Use of Methylation-Based DNA Discrimination”, Clinical Chemistry 56:10 1627-1635 (2010). cited by applicant O'Malley, R et al., “An adapter ligation-mediated PCR method for high-throughput mapping of T-DNA inserts in the Arabidopsis genome”, Nat. Protoc. 2, 2910-2917 (2007). cited by applicant PCT/US2014/51926, “International Search Report”, dated Dec. 9, 2014, 3 pgs. cited by applicant PCT/US2014/51926, “Written Opinion”, dated Dec. 9, 2014, 5 pgs. cited by applicant Roux, K H., “Optimization and troubleshooting in PCR”, Genome Research. PCR Methods and Applications vol. 4, 1995, 185-194. cited by applicant Srinivasan, et al., “Noninvasive Detection of Fetal Subchromosome Abnormalities via Deep Sequencing of Maternal Plasma”, The American Journal of Human Genetics 92, 167-176, Feb. 7, 2013. cited by applicant |
| Primary Examiner: | Vanni, G. Steven |
| Accession Number: | edspgr.10113196 |
| Database: | USPTO Patent Grants |
| Language: | English |
|---|